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Enzyme catalysed reaction rates produce a curved temperature dependence with 
a temperature optimum, Topt. Traditionally enzyme temperature dependence has 
been modelled by the Arrhenius and Eyring-Polanyi equations. Deviations from 
these models at elevated temperatures have traditionally been attributed to 
enzyme denaturation. Increasing evidence shows that enzyme denaturation is 
insufficient to fully explain the curvature for enzyme catalysed rates with 
temperature. 
Macromolecular rate theory (MMRT) accounts for these deviations from early 
models by introducing the concept of heat capacity (CP). During an enzymatic 
reaction, the heat capacity is reduced as the transition state complex forms (due 
to enzyme rigidification), resulting in an overall negative change in heat capacity 
(Δ‡) for the reaction. Heat capacity is a function of the number and energies of 
the vibrational modes for the individual molecules. Enzyme-ligand binding will 
influence the energies of the vibrational modes of the molecular complex 
therefore affecting an enzymes’ heat capacity and its catalytic rate via Δ‡ . 
Notably, a form of enzyme regulation (called allostery) utilises ligand binding at a 
site other than the active site to effect changes in catalytic rate.  
The underlying mechanisms of allostery are poorly understood. Here, the 
mechanisms of allostery are explored using a model isomaltase enzyme and 
MMRT to investigate changes in heat capacity. Several mutants of the model MalL 
enzyme were designed, produced and purified. These mutations aimed to either 
alter the structural integrity or mimic ligand binding in the C-terminal domain. 
Using a Stopped-Flow apparatus, these mutants were characterised kinetically and 
using crystallographic techniques, two structures were solved at high resolution.  
Targeted mutations approximately 30 Å from the active site showed significant 
changes in enzyme rate. Overall, the two new structures of MalL were very similar 
to the apo-enzyme showing only very minor structural deviations. Changes to the 
rate can thus be attributed to changes in enzyme dynamics and heat capacity. 
These results are a promising first step in linking changes in enzymatic activity with 
changes to enzyme dynamics and heat capacity, using MMRT as a model. 
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1.1 Enzyme Catalysis 
Enzymes have an extraordinary ability to catalyse chemical reactions such that 
they occur with dramatic rate improvements compared to the uncatalysed 
reaction. Enzymatic reactions can have rate improvements of up to 1017 times 
(Fersht, 1999). Understanding the mechanisms underlying these rate increases is 
therefore of considerable interest. In general, enzymes are considered to lower 
the activation energy of a reaction compared to the uncatalysed reaction. The 
activation energy (shown as ΔG‡ in Figure 1.1) is the difference in Gibbs free energy 
(ΔG) between the reactants (enzyme and substrate) (ES) and the transition state 
complex (ES‡). The Gibbs free energy (G) is a measure of the available energy in a 
system. A lower activation energy increases the rate of reaction due to an 
increased ability of the substrates to cross the activation energy barrier. The 
transition state is a high energy pseudo-intermediate that is formed during the 
conversion of substrate to the end product (Garrett & Grisham, 2013). 
 
 
Figure 1.1. Gibbs free energy changes along an enzyme-substrate reaction coordinate. 
Dashed line shows uncatalysed reaction with activation energy given by ΔG‡Uncatalysed. 
Solid line shows catalysed reaction with stabilisation of transition state (ES‡) and 




Enzymes use various methods to achieve this decrease in activation energy. 
Enzymes are highly specific for their substrates and it is this specificity which first 
gave insight into how enzymes may achieve their rate improvements. Strict 
enzyme specificity lead to the development of hypotheses on how enzymes 
interact with their substrates (Berg et al., 2015). The first model was the 
“lock-and-key” hypothesis, where the active site of the unbound enzyme is 
complementary in shape to the substrate, allowing the substrate to bind to the 
active site, which results in activation of the substrate (Fischer & Pinner, 1894). 
This however failed to provide any insight to the basis of an enzyme’s catalytic 
proficiency. Substrate binding was then proposed to bind in an “induced fit” 
mechanism, where the enzyme changes shape upon substrate binding, inducing a 
certain strain on it, introducing the first ideas on the mechanisms of enzyme 
catalysis (Haldane, 1930). 
The idea of induced fit was expanded with the hypothesis that the transition-state 
is stabilised by the enzyme – postulated by Pauling (1948), which lead to a new 
understanding of enzyme catalysis. Pauling’s understanding of how a molecular 
crystal structure developed by way of the complementarity of each molecule in 
the structure (excluding all other molecules that did not precisely fit) lead to his 
theory that the same mechanism is responsible for biological specificity (Pauling, 
1948). He proposed that enzymes are complementary in structure to the 
complexes of reactions that they catalyse, in other words, the transition state. His 
theory was that the enzyme has a detailed complementariness in molecular 
structure for the transition state which leads to a decrease in the energy of the 
complex of the two. This in turn would lead to a decrease in the energy of 
activation of the reaction, hence increasing the rate of the reaction (Pauling, 1948). 
Evidence for the induced fit and transition state stabilisation was provided by the 
crystal structure of lysozyme. The lysozyme structure was published in 1965 and 
was the first enzyme to have its structure solved (Blake et al., 1965). Following this, 
efforts turned to getting a crystal structure of lysozyme bound to a substrate 
(Phillips, 1966). Lysozyme catalyses the degradation of large chain polysaccharides 
such as peptidoglycan which consists of alternating units of N-acetylglucosamine 
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(NAG) and N-acetylmuramic acid (NAM). The structure of lysozyme was able to be 
solved with the trisaccharide (NAG)3 bound in the top portion of the active site 
cleft. It had been noted that NAG itself as well as the trisaccharide acted as an 
inhibitor of lysozyme. It therefore seemed likely that (NAG)3 bound as a 
competitive inhibitor in the same way as the substrate. This structure revealed the 
molecular details of the enzyme’s interaction with the substrate. The structure to 
the left of the active site cleft was found to shift to close the active site cleft when 
substrate is bound (Figure 1.2). In the substrate bound structure tryptophan 
residue 62 moves 0.75 Å to encompass the bound substrate (Phillips, 1966). This 
structural change upon ligand binding supported the induced fit model of enzyme-
substrate interactions.  
 
 
Figure 1.2. Crystal structure of lysozyme with (Blue; PDB: 1HEW) and without (Red; PDB: 
1LYZ) substrate (NAG)3 bound showing structural changes upon substrate binding. 
 
It was noted that the (NAG)3 substrate only filled half of the active site cleft. 
Additional sugar molecules were able to be modelled into the active site (Phillips, 
1966). For additional sugar units to bind, the fourth sugar unit was required to be 
bound in a distorted conformation. Lysozyme was found to cleave the glycosidic 
bond between the fourth and fifth sugar units. Two reactive amino acids (Asp52 
and Glu35) were identified in the vicinity of this bond. From this a mechanism for 
the catalytic activity of lysozyme was able to be proposed.  
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The cleavage of glycosidic bonds involves the formation of a carbenium ion 
intermediate. Lemieux and Huber showed in 1955 that when NAG incorporates a 
carbenium ion at carbon-1 (as it does during the lysozyme reaction) in the absence 
of enzymatic interactions it also adopts the same strained conformation shown by 
the fourth lysozyme sugar unit (Lemieux & Huber, 1955). This suggests that 
substrate binding to lysozyme favours the conformation that promotes formation 
of the carbenium ion required for catalysis (Phillips, 1966). The carbenium 
intermediate formed during the reaction is further stabilised by the two amino 
acids Asp52 and Glu35 (Benkovic & Hammes-Schiffer, 2003) (Figure 1.3). The 
interaction of residues implicit with substrate binding and hydrolysis provided 
evidence for the theory that the enzyme bound preferentially to the transition 
state (Phillips, 1966). 
 
 
Figure 1.3. N-acetylglucosamine substrate bound to lysozyme provides evidence for 
transition state stabilisation. Amino acids Asp52 and Glu35 are positioned to stabilise the 
formation of oxocarbenium intermediate. Adapted from Strynadka and James (1991). 
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1.1.1 Chemical Catalysis 
One of the ways enzymes catalyse reactions is by providing relevant chemical 
moieties in the correct orientations to provide chemical action to catalyse a 
reaction. There are three general mechanisms of enzyme chemical catalysis (Berg 
et al., 2015). 
1.1.1.1 Covalent catalysis 
Covalent catalysis utilises a reactive group that briefly becomes covalently 
attached to the substrate during catalysis. Covalent bonds involve the sharing of 
electron pairs. The reactive group often acts as a powerful nucleophile and 
participates in nucleophillic attack on the substrate to facilitate a reaction. 
Nucleophiles have excess electron density and can donate electron pairs to form 
a bond. For example, peptide proteases utilise covalent catalysis to catalyse the 
cleavage of peptide bonds by hydrolysis (Berg et al., 2015). During peptide 
hydrolysis water acts as a nucleophile to facilitate the cleavage of the peptide 
bond (Figure 1.4). 
 
 
Figure 1.4. Covalent catalysis is illustrated by peptide bond hydrolysis, which is 
facilitated by the addition of water (acting as a nucleophile) across the peptide bond. 
Adapted from Berg et al. (2015). 
 
The hydrolysis of a peptide bond is thermodynamically favoured but kinetically 
unfavoured. During hydrolysis the resonance of the peptide bond renders it 
resistant to hydrolysis (Berg et al., 2015). This is due to the sharing of electron 
density from the carbonyl group into the carbon-nitrogen bond by resonance, 
giving it a partial double bond character, which strengthens the bond and renders 
it resistant to hydrolysis (Figure 1.5). The carbonyl group is also less electrophilic 
(ability to accept electrons) and resists nucleophillic attack (Berg et al., 2015). An 
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enzyme must overcome this disfavoured kinetics and facilitate a nucleophillic 
attack on the carbonyl group to successfully facilitate peptide bond hydrolysis. 
 
 
Figure 1.5. Resonance of the peptide bond gives the carbon-nitrogen bond a partial 
double bond character, strengthening it and making it more difficult to hydrolyse. 
Adapted from Berg et al. (2015). 
 
A good example of this mechanism is the protease chymotrypsin. Chymotrypsin 
catalyses the cleavage of peptide bonds on the carboxyl side of large hydrophobic 
residues. It utilises a catalytic serine residue to facilitate a nucleophillic attack on 
the carbonyl group. During catalysis the serine residue is deprotonated by a 
nearby histidine residue forming a strongly nucleophillic alkoxide ion which 
attacks the peptide carbonyl to form a covalently bonded acyl-enzyme 
intermediate (Berg et al., 2015). The addition of water then allows for the release 
of the hydrolysed substrate and regeneration of the active site. 
1.1.1.2 Acid-Base catalysis 
In acid-base catalysis an enzyme residue plays the role of proton donor or acceptor 
in place of water. Acid base catalysis can stabilise charges on reaction 
intermediates by transfer of protons (Fersht, 1999). In general-base catalysis 
positive charges are stabilised by proton transfer to a base. Similarly, acid catalysis 
stabilises negative charges by donating a proton (Fersht, 1999). 
Alpha amylases are a group of enzymes that utilise an acid-base mechanism to 
catalyse the cleavage of glycosidic bonds (Davies & Henrissat, 1995). In this 
reaction the glycosidic oxygen is protonated by an acid group (A) with nucleophilic 
assistance from a base group (B), resulting in the formation of a glycosyl enzyme 
intermediate (Figure 1.6). This intermediate is hydrolysed by water producing the 




Figure 1.6. Acid Base catalysis of glycosidic cleavage by a retaining alpha-amylase. 
Glycosidic oxygen is protonated by acid group (A) with nucleophillic assistance from 
base group (B) forming a glycosyl enzyme intermediate. Intermediate is hydrolysed by 
water completing the reaction and regenerating the active site. Adapted from Davies 
and Henrissat (1995). 
 
1.1.1.3 Metal-Ion catalysis 
Metal ions can play several roles in catalysis (Berg et al., 2015). Metal ions can 
assist in the formation of nucleophiles by direct coordination. For example, zinc is 
used in carbonic anhydrase catalysis to stabilise the formation of the negatively 
charged hydroxide nucleophile utilised in the reaction (Figure 1.7). Metals can also 
stabilise negative charges in transition state intermediates by acting as an 
electrophile. This reduces the free energy of the intermediate which lowers the 
activation energy required for the reaction to occur. Metal ions can also assist in 
substrate binding and help to bind the substrate in the correct orientation for 
catalysis. Another important metal ion is magnesium. For example, many ATP 
binding enzymes use magnesium to bind ATP (Maguire & Cowan, 2002). The 
magnesium ion has a large hydration sphere so can help to position water 
correctly for participation in the enzymatic mechanism (Maguire & Cowan, 2002). 
 
 
Figure 1.7. Zinc assists in the formation of hydroxide nucleophile utilised in the catalytic 




1.1.2 Dynamic mechanisms of enzyme rate acceleration 
1.1.2.1 Ground state destabilisation 
Rate improvements in enzyme catalysis can occur by either raising the energy of 
the enzyme bound to substrate (ES), known as the ground state or lowering the 
energy of the transition state complex (TS), either of which will lower the 
activation energy required for a reaction (Figure 1.8).  
 
 
Figure 1.8. Enzyme rate improvements can be achieved by lowered activation energy 
(ΔGo‡). Dashed line shows increased energy of ground state (ES) and lowered energy of 
transition state (TS) resulting in lowered activation energy (double arrow head dashed 
line). 
 
Substrate binding to the enzyme results in an important catalytic compromise. 
There is a small release of Gibbs free energy during substrate binding (ΔGbinding) 
(Berg et al., 2015). This results in the ES complex having a lower energy state (or 
in other words a negative binding energy), however this ensures that binding of 
the substrate is favourable (Figure 1.9). This interaction should however not be 
too strong as a large ΔGbinding will increase the activation energy required to 
perform the reaction unreasonably and catalytic efficiency will be lost. This can be 
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countered by entropic effects of substrate binding to the enzyme leading to the 
destabilisation of the ground state (Fersht, 1999).  
 
 
Figure 1.9. Effect of free energy release upon substrate binding on the activation energy 
required for enzyme catalysis. Blue line shows non-catalysed reaction with activation 
energy, ΔG°‡non. Red line shows enzyme catalysed reaction with activation energy, 
ΔG°‡cat. ΔG°‡cat increases as the ground state (ES) is stabilised and ΔG°binding is increased 
(Appling et al., 2019).  
 
Ground state destabilisation is one of the mechanisms enzymes use to raise the 
energy of the ES complex to ensure that the activation energy is not unnecessarily 
large due to excessive ΔGbinding. Ground state destabilisation places a strain on the 
bound substrate to increase the energy of the ground state through electronic 
strain, bond distortion and conformational restriction (Berg et al., 2015). 
Electronic strain is an effect of the non-zero electric field present at the active site 
of an enzyme. The electric field generates a force on the substrate destabilising 
the ground state. The strength of this interaction depends on the strength of the 
electric field and the polarizability of the substrate. Tonge and Carey found that 
the energy involved in this interaction was almost completely reflected by a 
decrease in the activation energy (Tonge & Carey, 1992).  
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Bond distortion occurs when a substrate binds to an enzyme such that its bonds 
are either stretched or rotated. It was first suggested in 1930 that glycosidases 
bind their substrates in such a way that the glycosidic bond in strained (Haldane, 
1930). This was later confirmed with the structure of the lysozyme and other 
glycosidic enzymes (Davies et al., 1998; Phillips, 1966). 
Ground state destabilisation can occur by a number of mechanisms. For example, 
substrate conformational restriction raises the free energy of the substrate by 
decreasing its entropy. In other words, in the enzyme substrate complex, there are 
fewer possible conformational states for the substrate and its entropy is 
decreased. For example, the glycoside hydrolase Cel5A from the bacteria 
Bacillus agaradhaerens binds its ribose substrate in a skew boat configuration. In 
this orientation the substrate is bound in a higher energy configuration, which 
contributes to the catalytic proficiency of the enzyme (Davies et al., 1998). 
1.1.2.2 Catalysis by Approximation 
For reactions with two substrates, the catalytic rate can be enhanced by providing 
a site for the two substrates to interact in the correct geometry for a reaction to 
occur (Berg et al., 2015). This increases the effective concentration of a substrate 
in solution. Binding of substrates confines the degrees of freedom (independent 
motion) and therefore lowers the entropy. This decrease in entropy by substrate 
binding lowers the overall entropy change for the reaction, thereby increasing the 
rate (Fersht, 1999). 
 
1.2 Enzyme Kinetics 
The most widely used model to understand enzyme kinetics is the Michaelis-
Menten model developed by Leonor Michaelis and Maud Menten in 1913 (Fersht, 
1999). Many enzymes follow Michaelis-Menten kinetics. Enzymatic reactions can 
be thought of as two parts, a reversible binding step, and a largely irreversible 
catalytic step (Chen et al., 2010). This scheme produces Equation 1.1 where the 
rate of the substrate binding is given by k1 and the rate of product formation is 
given by kcat. 
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Equation 1.1. Michaelis-Menten reaction scheme 
 
 
The study of enzyme kinetics relies on the steady state approximation method. In 
this, it is assumed that the concentration of the enzyme substrate complex (ES) 
does not change (Berg et al., 2015). This allows rates to be described with 
simplified equations. For the steady state approximation to hold, the kinetics are 
studied with excess substrate. Under these conditions the enzymes’ rate is defined 
by the substrate concentration. As the substrate concentration increases the rate 
increases until it approaches the maximal rate (Vmax) as shown in the rate versus 
substrate concentration curve below (Figure 1.10).  
 
 
Figure 1.10. Michaelis-Menten Kinetics of an enzyme. Catalytic rate increases until 
enzyme is saturated and maximal rate (Vmax) is reached. KM is defined by the substrate 




An increase in rate as substrate concentration increases can be modelled by the 
Michaelis-Menten equation (Equation 1.2) which includes terms for the maximum 
rate and the Michaelis constant (KM) (Berg et al., 2015).  
 
Equation 1.2. Michaelis-Menten equation 
 =  
[] + [] 
 
KM is the equilibrium constant for substrate binding and is found on the graph in 
Figure 1.10 at the substrate concentration whereby the enzyme is performing at 
half of its maximal rate. It is also a variable that provides important information 
about the affinity of the enzyme for the substrate.  
Another important measure of reactant rate is kcat which can be calculated from 
Vmax by Equation 1.3 (where [E]T represents total enzyme). kcat provides a substrate 
independent measure of catalytic rate and represents the turnover of an enzyme 
per unit time. 
 
Equation 1.3. Calculation of kcat 

 = []  
 
1.3 Allostery 
Allostery is the mechanism in which the effect of a ligand binding at a site distal to 
the active site, is transmitted through the enzyme allowing for the regulation of 
enzyme activity (Motlagh et al., 2014). Allostery was first observed in the early 20th 
century by Christian Bohr who described the effect of carbon dioxide on oxygen 
binding to haemoglobin (Liu & Nussinov, 2016). Bohr observed that the affinity of 
haemoglobin for oxygen decreased as the partial pressure of carbon dioxide 
increased. The term allostery was coined by Jacques Monod and Francois Jacob in 
1961 to describe enzyme inhibition where the inhibitor did not mimic the 
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substrate and exerted its effect by binding in its own distinct site away from the 
active site (Liu & Nussinov, 2016). In the following years two models were 
proposed to describe allostery, the KNF model by Koshland, Nemethy and Filmer 
(Koshland et al., 1966), and the MWC model by Monod, Wyman and Changeaux 
(Monod et al., 1965). Both the KNF and MWC models described allostery in terms 
of conformational changes, a concept that would dominate until recent years 
when a more dynamic view of allostery began to emerge (Liu & Nussinov, 2016). 
Despite these advances, the detailed mechanisms of allostery are not well 
understood. 
 
1.3.1 Conformational models of allostery 
The conformational models of allostery were heavily influenced by the allosteric 
effects observed in haemoglobin. The two main conformational models are the 
MWC and KNF models. Both of these models are phenomenological. That is, they 
both describe the action of allostery, without providing a suitable mechanism for 
the underlying changes (Cui & Karplus, 2008). 
1.3.1.1 Monod-Wyman-Changeaux (MWC) Model (Symmetry model) 
The core principle of the MWC model is that there is an equilibrium between two 
coexisting quaternary structural conformations (Eaton et al., 2007). The MWC 
model requires a number of assumptions to be made. The allosteric protein must 
be an oligomer and exist in two states, a tense state (T) and a relaxed state (R) 
(Fersht, 1999). All subunits are assumed to have the same conformation and 
therefore the MWC model is also referred to as the symmetry model. The T state 
is more constrained than the R state and has a lower affinity for ligands. This lower 
affinity T state is more prevalent in the absence of ligands (Fersht, 1999). In each 
state equivalent binding sites on each monomer are identical and have equal 
binding affinities (Fersht, 1999). A central tenet of the MWC model is that both 
the T and R states are available independently of substrate or allosteric regulators 
being present. Allosteric regulators do not function by directly altering the 
structure of the T or R states, but by indirectly shifting the equilibrium between 
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these two states (Eaton et al., 2007). In the MWC model allosteric enzymes are 
oligomeric with internal structural symmetry. The structural shift between the two 
states occurs by a rotation of monomer units. During this rotation symmetry in the 
oligomer is conserved (Cui & Karplus, 2008) (Figure 1.11).  
The MWC model provided a simple explanation for allosteric control. It had been 
noted that many allosteric enzymes produced a sigmoidal rate vs substrate 
concentration curve in the absence of allosteric regulators (Figure 1.12). This is 
proposed to be the result of the substrate binding preferentially to the R state 
shifting the equilibrium to this state making it easier for additional substrate 
molecules to bind which produces a sigmoidal curve (Fersht, 1999). An allosteric 
activator functions by binding to the R state, increasing its concentration by 
shifting the equilibrium towards the R state. In some cases an allosteric activator 
may increase the prevalence of the R state to such an extent that the sigmoidal 
rate curve is shifted to show Michaelis-Menten kinetics (R-state curve) (Fersht, 
1999). Whereas an allosteric inhibitor functions by binding to the T state and 




Figure 1.11. MWC model. Allostery is mediated by a conformational shift between the 
catalytically inactive tense state (T) and the active relaxed state (R), where substrate (S) 
can bind. Equilibrium between T and R can be shifted by binding of an inhibitor (I) or 





Figure 1.12. MWC Kinetics. An enzyme following MWC kinetics shows a sigmoidal (Black) 
rate curve. Addition of an inhibitor shifts rate curve to T-state kinetics (Pink). Addition 
of an activator shifts rate curve to R-state kinetics (Blue). Adapted from Berg et al. 
(2015).  
 
1.3.1.2 Koshland-Nemethy-Filmer (KNF) Model (Sequential model) 
Similar to the MWC model, the KNF model assumes there exists two states T and 
R. It relies on the induced fit model of binding, where a ligand binding induces 
structural changes in the enzyme. As an allosteric activator binds to the T state a 
series of sequential tertiary structural changes occur that can be transmitted 
between connected subunits, which results in a switch to the R state (Fersht, 1999) 
(Figure 1.13). The KNF model is also termed the sequential model due to this 
phenomenon. Unlike the MWC model structural changes conveyed by the KNF 
model can induce a negative structural change resulting in decreased binding of 
subsequent ligands (negative cooperativity), while the MWC model can only 





Figure 1.13. KNF Model. Allostery is mediated by ligand binding (L) inducing a sequential 
conformational change (from T (square) to R (circle)) that alters the enzymes’ binding 
affinity for subsequent ligands. Adapted from Garrett and Grisham (2013). 
 
1.3.1.3 Stereochemical Model 
Both the MWC and KNF models did not offer any insight into the mechanisms of 
allosteric communication between the allosteric binding site and the active site. It 
was the advent of X-ray crystallography and structural biology that allowed new 
insights into the function of allostery. The first structure of haemoglobin (the 
classical model for allostery and the basis for the MWC and KNF models) was 
published by Max Perutz in 1960 (Perutz et al., 1960). Following the later 
structures of oxy- and deoxy-haemoglobin Perutz hypothesised that allostery 
could be understood by careful structural analysis of allosteric enzymes (Motlagh 
et al., 2014). Perutz showed that a small number of salt bridges mediate the 
conformational changes between allosteric states in haemoglobin (Hilser et al., 
2012). In addition to this it has also been hypothesised that allostery is mediated 
by conserved allosteric pathways that transmit communications between the 
allosteric and active sites (Motlagh et al., 2014). It has been proposed that these 
pathways consist of a set residues that are in dynamic contact that transmit a 





Figure 1.14. Allosteric pathways transmit perturbation at the allosteric site to the active 
site through conserved pathways (del Sol et al., 2009). 
 
1.3.1.4 Limitations of structural approaches to allostery 
Although these models have found widespread application, they do not represent 
a complete view of allostery, and do not offer any insights into allosteric 
mechanisms. Under these models allostery is mediated by structural shifts in 
oligomeric proteins and so is limited to oligomers, however allostery has been 
seen in monomeric proteins. The MWC model is limited by its requirement for 
symmetry. Certain allosteric regulators can be both activators or repressors under 
different conditions, a property not accounted for by current conformational 
models (Hilser et al., 2012).  
 
1.3.2 Protein dynamics approach to allostery 
The role of dynamics as a mechanism for allostery rather than conformational 
changes was first hypothesised by Cooper and Dryden in 1984 (Cooper & Dryden, 
1984). Enzymes were beginning to be seen as dynamic molecules that could 
undergo various forms of intramolecular motion, not simply the static molecules 
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that had previously been believed (Cooper & Dryden, 1984). Cooper and Dryden 
showed that allostery could arise from changes in conformational dynamics 
(statistical distribution of possible conformations) caused by changes in thermal 
fluctuations caused by ligand binding (Motlagh et al., 2014). It was also noted by 
Cooper and Dryden that rate processes that utilise thermal fluctuations such as 
catalysis, and ligand binding and dissociation may be regulated by dynamic 
processes (Cooper & Dryden, 1984).  
A paper published by Colombo and colleagues in 1992 showed the importance of 
dynamic effects in allostery (Colombo et al., 1992). They showed that the 
structural transition involved in haemoglobin allostery also involved the additional 
binding of approximately 60 water molecules (Colombo et al., 1992). This extra 
hydration stabilised the conformational change revealing the role of the entire 
molecule in the allosteric mechanism (Motlagh et al., 2014).  
1.3.2.1 Ensemble model 
The ensemble allosteric model is a model which redistributes the two states found 
in the MWC model as a statistical ensemble (distribution of possible 
conformations). In the ensemble model an enzyme is treated as two separate 
domains that can interact (Hilser et al., 2012). As a general case one domain is the 
allosteric domain and the other the catalytic domain. Each domain can 
independently sample multiple conformations based around a statistical average. 
In the simplest case there are two states the low affinity T state and the high 
affinity R state. When a conformational transition occurs in one domain, for 
example by binding a ligand, the probability of the other domain being in the low 
affinity T state is altered (Hilser et al., 2012).  
1.3.2.2 Molecular dynamics in allostery 
Enzymes exist as an ensemble of different conformations (Marino et al., 2018). 
Crystallography techniques present only a static view of protein conformation, so 
therefore do not represent a full view of enzyme dynamics. Molecular dynamics 
(MD) simulations can probe conformational variability at atomic level resolution 
(Marino et al., 2018). Molecular dynamics uses Newtonian mechanics to predict 
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the position of atoms as a function of time rather than computationally intensive 
quantum mechanical models (Hertig et al., 2016). Perturbations can then be 
introduced to the system and their effects studied (Hertig et al., 2016). MD 
simulations can be used to study and predict the physical properties (such as 
stability and dynamics) of proteins or their interactions with other molecules.  
 
1.4 The temperature dependence of reaction rates 
The relationship between reaction rates and temperature was first formalised by 
Svante Arrhenius in the 19th century, based on empirical observations (Equation 
1.4).  
 
Equation 1.4. Arrhenius Equation 
 =  ⁄  
 
Arrhenius expanded on the earlier work of Jacoubus Henricus van’t Hoff to 
describe the rates of simple chemical reactions including defining a term for the 
activation energy of a system (EA) (Justi & Gilbert, 1999). Arrhenius described the 
rate as being exponentially related to the activation energy divided by 
temperature. A pre-exponential term was included to describe the frequency of 
collisions between reactant molecules. Arrhenius proposed that the necessary 
energy for a reaction to proceed was associated with an energy barrier, and it was 
the proportion of reacting molecules in this higher energy or ‘active’ state which 
conveyed the temperature dependence of chemical rates (Justi & Gilbert, 1999). 
Due to the exponential nature of the equation small changes in temperature result 
in an exponential change in reaction rate. 
The Arrhenius equation was expanded independently by Michael Polanyi and 
Meredith Evans, and Henry Eyring in 1935. Aspects of previous thermodynamic, 
kinetic and statistical models were unified into a new comprehensive model, 
Transition State Theory (TST) (Justi & Gilbert, 1999). Under TST consideration was 
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given to the transition of molecules from reactant to product. Reactants were 
considered to pass through a continuous set of defined configurations between 
reactants and products (Evans, 1938). The rate of a chemical reaction was 
therefore redefined such that consideration was given to both the thermodynamic 
considerations of reaction rates though an intermediate transition state species, 
as well as the kinetics of molecule collisions (Justi & Gilbert, 1999). TST led to the 
development of the Eyring-Polanyi equation, which included additional terms, the 
Boltzmann constant (), Planck’s constant (ℎ), and the Gibbs free energy change 
between the reactant state and transition state (ΔG‡) (Equation 1.5).  
 
Equation 1.5. Eyring equation 
 = !"ℎ # $%
‡ ⁄  
 
It is often assumed that ΔG‡ is linearly dependant on temperature and thus ΔG‡ 
varies with temperature according to the equation ΔG‡ = ΔH‡ - T ΔS‡ (Arcus et al., 
2016). The Eyring equation (Equation 1.5) can thus be represented as Equation 1.6 
by the substitution of ΔG‡ for its components, which is also equivalently 
represented as Equation 1.7. 
 
Equation 1.6. Expanded Eyring equation 
 = !"ℎ # &
'(‡ ) &'*‡ ) 
Equation 1.7. Expanded Eyring equation 








1.4.1 Temperature dependence of biological macromolecules 
The Arrhenius and Eyring equations have traditionally been applied to biological 
systems as well as simple chemical systems. It has been widely accepted that the 
deviation from these models at elevated temperatures in biological systems is 
caused by irreversible thermal denaturation. An enzyme following the 
Arrhenius/Eyring models is expected to show an exponential increase in rate with 
temperature (Figure 1.15A), however it has been noted that many enzymes show 
much slower and non-exponential rate increases (Thomas & Scopes, 1998) (Figure 
1.15B). Enzymes have also been observed to show a maximum rate (Topt) and 
subsequent decrease with temperature before thermal denaturation becomes 
significant (Thomas & Scopes, 1998). This is especially true for many psychrophilic 
enzymes which show decreases in rate at temperatures well below their thermal 
denaturation temperatures (Feller & Gerday, 2003). This suggests that enzyme-
catalysed rates have a more complex temperature dependence than is described 
by the Eyring equation (Arcus et al., 2016). 
 
 
Figure 1.15. Models of Temperature dependence. A) Arrhenius and Eyring models 
produce an exponential increase in rate with temperature. B) Enzymes show a non-
exponential rate increase with a maximal rate and subsequent decrease with 
temperature (psychrophilic (Black) and mesophilic (Blue) enzymes). Adapted from Arcus 




1.4.2 Macromolecular rate theory (MMRT) 
An alternative explanation to model observed enzyme catalysed rates is MMRT, 
which incorporates a value for the activation heat capacity (23‡) into the rate 
equation (Hobbs et al., 2013). Heat capacity can be defined as the ability of a 
system to absorb energy without changing temperature. Proteins are large 
molecules that have a correspondingly large heat capacity. It has been shown that 
the largest contribution to a protein’s heat capacity is the number of accessible 
vibrational modes as well as a small contribution from the solvation interaction 
between the protein and the aqueous environment (Gómez et al., 1995). Heat 
capacity defines the temperature dependence of the entropy and enthalpy of 
reaction based on Equation 1.8. Substituting the temperature dependence of 
entropy and enthalpy into the Eyring equation (Equation 1.7) gives the MMRT 
equation (Equation 1.9). 
 
Equation 1.8. Temperature dependence of enthalpy and entropy 
245‡ = 6205‡ + 23‡-" − ".7 − "625‡ + 23‡8ln-". − ln-".;7 
Equation 1.9. MMRT equation 
ln-. = ln !"ℎ # −
205‡ + 23‡-" − ".1" +
25‡ + 23‡8ln-". − ln-".;1  
 
23‡ can also be temperature dependant. Adding a temperature dependant heat 
capacity gives Equation 1.10. This adds a new factor A which quantifies the 
temperature dependence of 23‡.  
 
Equation 1.10. MMRT equation with temperature dependent ΔCP‡ 
ln-. = ln !"ℎ # −
205‡ + 623,5‡ + -" − ".7-" − ".1"
+ 25
‡ + 623,5‡ + -" − ".7ln = "">1  
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Heat capacity adds a new dimension of understanding to enzyme catalysed rates. 
23‡ is the difference in heat capacity between the enzyme-substrate complex and 
enzyme-transition state complex. This is influenced mostly by the change in the 
frequencies of vibrational modes between the two aforementioned states (Arcus 
et al., 2016). Enzymes generally have a large negative 23‡ due to tight binding of 
the enzyme to the transition state resulting in a shift of the vibrational modes to 
higher frequencies. MMRT produces a curved temperature dependence (Figure 
1.16). The degree of curvature is defined by the value of 23‡. As 23‡ gets more 
negative the curvature of the temperature dependence becomes more prominent. 




Figure 1.16. Temperature dependence of enzyme rates. Arrhenius and Eyring models 
(Black) produce a linear temperature dependence. MMRT (Blue) produces a curved 
temperature dependence. Degree of curvature is dependent on the value of ΔCP‡. 




1.5 X-ray Crystallography 
X-ray crystallography is a tool for probing the structure of molecules, including 
proteins. X-ray crystallography is based on the interaction of X-rays with 
elementary particles and utilises the scattering of X-rays by electrons (Drenth, 
1999). The intensity of X-ray scattering is dependent on the number of electrons 
per atom (Blow, 2002). The X-rays used in X-ray diffraction (XRD) are 
monochromatic. When an X-ray hits an electron some of the energy is absorbed 
and reemitted at the same wavelength as a spherical wave. When this process 
occurs in a regular lattice such as a crystal, diffracted X-rays add up at specific 
angles relative to the angle of incident radiation (Blow, 2002). When distances in 
the lattice correspond to integer multiples of the incident wavelength diffracted 
X-rays will add up constructively. When diffracted X-rays line up in-phase of the 
waves they add up constructively. If they line up out of phase of the waves, they 
add up destructively (Figure 1.17) (Drenth, 1999). This is defined mathematically 
by Braggs law (Equation 1.11). 
 
 
Figure 1.17. Braggs Law. A) Diffracted X-rays line up when the waves are in phase and 
add constructively, leading to amplification of signal. B) Diffracted X-rays line up out of 
phase of the waves and add up destructively. Adapted from Dang Ngoc Chan (2011). 
 
Equation 1.11. Braggs Law 




When crystals are irradiated with X-rays a diffraction pattern is produced (Blow, 
2002). Each spot, called a reflection, corresponds to a particular set of planes of 
the crystal in reciprocal space. The position and intensity of each reflection gives 
information about the electron density in a given plane. By rotating the crystal, a 
full 3D picture of the electron density can be built (Blow, 2002). Electron density 
is calculated by performing a mathematical operation called a Fourier transform 
on the intensity data. The intensity is a product of wave interactions and is 
determined by the amplitude and phase of the diffracted radiation. The phase 
cannot be determined experimentally so must be determined by another method, 
such as molecular replacement, anomalous scattering or isomorphous 
replacement (Drenth, 1999). 
 
1.5.1 Protein Crystallography 
Due to the periodicity of a crystal the observed intensities are much stronger. The 
amplitude of diffracted X-rays is linearly dependant on the number of points in the 
scattering lattice (Blow, 2002). A well-formed, large crystal produces the best 
formed lattice to produce maximal diffraction. Therefore, significant effort is put 
into obtaining sufficient quality crystals for X-ray diffraction.  
Protein crystals are grown from supersaturated conditions. The conditions should 
provide supersaturation for the protein but not significantly perturb its normal 
state (McPherson & Gavira, 2013). Protein crystals are usually grown in aqueous 
solution with additives and salts to promote crystallisation. A common method to 
achieve supersaturation is the ‘hanging-drop’ where a small drop containing 
protein and crystallisation solution is suspended above a reservoir solution 
containing only crystallisation solution (Figure 1.18). This sealed environment 
allows vapour diffusion to occur which results in a net movement of water into the 





Figure 1.18. Hanging-drop vapour diffusion method of protein crystallisation. A mixed 
protein drop is suspended above an unadulterated reservoir solution. Vapour diffusion 
results in water loss increasing protein saturation and promoting crystallisation.  
 
There are two stages to crystallisation, nucleation and growth. The nucleation 
stage is poorly understood. During this period small aggregates form which 
become the nuclei for crystal growth (McPherson & Gavira, 2013). It has been 
suggested that crystals arise from critical nuclei that form in a distinct liquid 
protein phase that forms in saturating protein solutions (Wolde & Frenkel, 1997). 
Protein crystals then grow from the formed nuclei. The attachment of new 
molecules occurs at steps on the crystals surface, as it is more energetically 
favourable to bind at these steps. Steps are formed by defects in the crystal order 
or at nuclei that form randomly on the crystal surface (Drenth, 1999). 
The conditions under which crystals will grow is difficult to predict and typically 
relies on screening a large number of conditions to identify potential conditions 
(McPherson & Gavira, 2013). These identified conditions can then be 
systematically altered to optimise crystal growth. The three general factors for 
crystallisation conditions are pH, ionic strength and precipitant. Changing the pH 
alters the ionisation state of surface amino-acid residues and can alter the degree 
of attraction between protein molecules (McPherson & Gavira, 2013). Precipitants 
interact with the solvent in such a way that that the protein saturation is altered 
to promote crystallisation. Similarly, salts compete with proteins for interactions 
with water, promoting crystallisation (McPherson & Gavira, 2013). 
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1.6 Glucosidase MalL from Bacillus subtilis as a model enzyme 
MalL is an enzyme involved in maltose utilisation in Bacillus subtilis. MalL was 
identified as a putative α-glucosidase encoded by the yvdL open reading frame, 
which was identified as part of the B. subtilis genome sequencing project 
(Schönert et al., 1998). MalL was characterised as a specific 
Oligo-1,4-1,6-α-glucosidase (sucrase-isomaltase-maltase). The activity of MalL can 
be followed spectroscopically at 405 nm by the cleavage of 
p-nitrophenyl-α-D-glucopyranoside (PNG).  
MalL is part of the glycoside hydrolase superfamily of enzymes. Based on 
structural and mechanistic similarities glycoside hydrolases can be further divided. 
MalL and other Oligo-1,6-α-glucosidases are members of the group 13 glycoside 
hydrolases (GH-13) or the GH-H clan. GH-13 enzymes share a conserved structure. 
The catalytic core (domain A) consists of an 8-stranded β/α barrel first described 
in the enzyme triosephosphate isomerase (TIM). A second domain (B) protrudes 
between β3 and α3 and forms part of the active site structure. GH-13 enzymes also 




Figure 1.19. Domain architecture of the Bacillus subtilis isomaltase enzyme MalL. 
Domain A (Blue) is the catalytic TIM barrel. Domain B (Red) is a β3 to α3 extension. 
Domain C (Green) is a C-terminal all-β Greek key domain. 
 
MalL has been extensively used as a model for MMRT. MalL is a relatively large 
monomeric enzyme which lends itself well to studying dynamic effects (such as 
during MMRT). MalL is particularly stable, and its activity can be easily measured 
using a direct assay. Various MalL mutants have been well characterised during 
previous investigations which have contributed to the development of the MMRT 





Figure 1.20. Characterisation of a range of individual MalL mutants have contributed to 
the development of the MMRT enzymatic model (Hobbs et al., 2013). Arrows indicate 
the Topt for each enzyme. 
 
In addition to this characterisation, 3D structures (achieved via protein 
crystallography) have been obtained for wild type (WT) MalL, the V200A, V200S 
and G202P variants as well as MalL bound to the transition state analogue 
1-deoxynojirimycin (Hobbs et al., 2013; van der Kamp et al., 2018) and bound to 
urea (unpublished). Acquiring a range of 3D structures of MalL thus far has 
contributed to the knowledge of the dynamic mechanisms of this enzyme and to 




1.7 Aims of MSc project 
The aim of this project was to use MMRT as a tool to determine how allosteric 
enzyme regulation may be interpreted by changes in enzyme heat capacity along 
the reaction coordinate. To test this experimentally we use the model enzyme 
MalL and generate and characterise of a range of MalL mutants. Mutants are 
characterised by using activity assays to determine Michaelis-Menten kinetics and 
over a range of temperatures in order to be modelled using MMRT. This allows us 
to determine heat capacity changes and infer changes to the enzyme’s dynamics 
along the reaction coordinate. In addition, protein crystallography techniques are 




2 Materials and methods 
2.1 Protein production and purification 
2.1.1 Buffers and Media 
Composition of general buffers and media used in all experiments is given in Table 
2.1. 
 
Table 2.1. General Buffers and Media 
Solution Components 
LB media 10 g L-1 NaCl, 10 g L-1 tryptone, 5 g L-1 yeast extract 
LB Agar 
10 g L-1 NaCl, 10 g L-1 tryptone, 5 g L-1 yeast extract, 
15 g L-1 agar 
Lysis buffer 
10 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 25 mM imidazole, 
pH 7.0 
Elution buffer 




20 mM HEPES, pH 7.8 
Assay buffer 40 mM Na2PO4, 150 mM NaCl, pH 8.0 
 
2.1.2 Protein Expression 
A glycerol stock of DH5α Escherichia coli containing the Bacillus subtilis isomaltase 
gene (MalL) (wild type and S536R variant) in the pPROEX-Htb expression vector 
was provided by E. Prentice. Single colonies were isolated by plating on a LB agar 
plate with 0.1 mg mL-1 ampicillin and grown overnight at 37°C.  
2.1.2.1 Glycerol Stocks 
Glycerol stocks were made adding equal volumes of 50% v/v glycerol and bacterial 
culture and stored at -80°C.  
Chapter two 
32 
2.1.2.2 Expression protocol 
Glycerol stocks were used to inoculate 20 mL starter cultures in LB media with 
0.1 mg mL-1 ampicillin. Cultures were grown overnight at 37°C with shaking at 
180 rpm. Starter cultures were used to seed 1 L LB expression cultures in a 2 L 
baffled flask with 0.1 mg mL-1 ampicillin and 0.2% w/v glucose. Expression cultures 
were grown at 37°C with shaking at 180 rpm until OD600 was approximately 0.5-0.7. 
Protein expression was induced with 0.75 mM IPTG and expressed at 18°C with 
shaking at 180 rpm overnight. Cells were harvested by centrifugation at 4542 g for 
20 min at 4°C. Pelleted cells were stored at -20°C until purification. 
 
2.1.3 Protein purification 
Cells pellets were defrosted on ice and resuspended in approximately 20 mL Lysis 
buffer by vortexing. Cells were lysed on ice by sonication at level five with three 
30 second bursts with 30 seconds of cooling between each sonication (Ultrasonic 
processor XL, Misonix, USA). Soluble protein was obtained in the supernatant by 
centrifugation at 13946 g for 20 minutes at 4°C. Protein containing supernatant 
was filtered through 1.2, 0.45, and 0.2 μm Minisart syringe filters (Sartorius, 
Germany) before being purified by immobilised metal affinity chromatography. 
2.1.3.1 Immobilised metal affinity chromatography (IMAC) 
Protein was purified using IMAC based on the N-terminal hexa-His tag affinity for 
Nickel. The HisTrap FF (5 mL, GE Healthcare, UK) column was prepared by stripping 
with two column volumes of EDTA (100 mM, pH 8.0) and then washing with two 
column volumes of MQ H2O. The column was then recharged with one column 
volume of 100mM NiCl2 and washed with two column volumes of MQ H2O. The 
column was then equilibrated with Lysis buffer before loading filtered protein. 
Protein elution was performed on an Äkta Basic or Purifier FPLC system. 
Non-target protein was washed from the column using 4% Elution buffer and 96% 
Lysis buffer at 1 mL min-1, until absorbance at 280 nm had plateaued. Protein was 
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eluted from the column using a 0-100% gradient over 50 mL at 1 mL min-1 and 
collected in 2 mL fractions. Elution was followed by UV trace at 280 nm. 
2.1.3.2 Size exclusion chromatography (SEC) 
SEC was performed on a HiLoad 16/60 Superdex 200 pg (GE Healthcare, UK) 
column on a Äkta Basic FPLC. The column was equilibrated with size exclusion 
buffer. Protein was concentrated to approximately 5 mL prior to loading onto the 
column via a 5 mL injection loop. Elution was performed using size exclusion buffer 
at 0.5 mL min-1 and protein was collected in 2 mL fractions. Elution was followed 
by UV trace at 280 nm.  
 
2.1.4 Polyacrylamide gel electrophoresis (PAGE) 
All PAGE gels were made as native gels (no SDS) and run with an SDS running buffer. 
Native PAGE gels were made with 12% acrylamide resolving layer with a 5% 
acrylamide stacking layer. Gels were made five at a time according to the scheme 
in Table 2.2. Gels were run with 1 X Tris Glycine-SDS (Sodium dodecyl sulphate) 
running buffer. Samples were prepared with 1:4 of 4 X SDS loading dye. Buffer 
compositions are given in Table 2.3. 
 
Table 2.2. Components of PAGE Gel 
Component Resolving gel (mL) Stacking gel (mL) 
MQ H2O 10.35 8.625 
30% w/v Acrylamide 12 2.125 
Buffer (Resolving or Stacking) 7.5 1.6 
10% w/v APS 0.15 0.0063 




Table 2.3. Buffer compositions for PAGE 
Solution Composition 
4 X SDS loading 
dye 
250 mM Tris (pH 6.8), 20% glycerol, 4% SDS, 10% 
mercaptoethanol, 0.025% w/v bromophenol blue 
TG-SDS running 
buffer 
25 mM Tris, 250 mM glycine, 0.1% SDS 
Resolving 
buffer 
1.5 M Tris, pH 8.0 
Stacking buffer 1.0 M Tris, pH 6.8 
 
Samples were stained by Fairbanks A staining solution (0.05% Coomassie blue, 25% 
isopropanol, 10% acetic acid) (Wong et al., 2000). Background staining was 
removed using Fairbanks D stain (10% acetic acid). Gel images were captured using 
the Omega Lum G imaging system (Aplegen, USA) and processed using 
RawTherapee 5.7 software and annotated in Microsoft PowerPoint. 
 
2.1.5 Measuring protein concentration 
Protein concentration was measured by UV at 280 nm using the Nanodrop 2000 
spectrophotometer (ThermoFischer Scientific, USA). Protein concentration was 
corrected with the extinction coefficient as calculated by ProtParam (Gasteiger et 
al., 2005) based on the protein sequence. 
 
2.1.6 Protein concentration 
Protein was concentrated to the appropriate volume or concentration using 
Amicon Ultra (Merck Millipore, USA) spin concentrators with a 10 kDa molecular 




2.2 Kinetic assay procedure 
Enzymatic activity of MalL can be followed by the cleavage of 
p-nitrophenyl-α-D-glucopyranoside (PNG) into glucose and p-nitrophenol. The 
production of p-nitrophenol can be followed spectroscopically at 405 nm. Assays 
were performed with a 1:1 ratio of enzyme in size exclusion buffer and substrate 
(PNG) in assay buffer. Additional assay components (GuHCl, indole; Sigma-Aldrich, 
USA) were included at the relevant concentration with substrate in assay buffer. 
A molar extinction coefficient of 13270 M-1 (405 nm, pH 8) was used in subsequent 
kinetic calculations (Kraakman, 2017). 
 
2.2.1 Michaelis-Menten Assay 
Michaelis-Menten assays were performed on the stopped-flow 
spectrophotometer (Tgk Scientific, UK). MalL at 0.026 mg mL-1 in size exclusion 
buffer was mixed 1:1 with appropriate substrate concentration in assay buffer, 
resulting in a final enzyme concentration of 0.013 mg mL-1. Temperature control 
was achieved using a circulating water bath connected to the observation cell on 
the stopped-flow spectrophotometer. Accurate temperature measurements were 
achieved using a thermocouple. Reaction was repeated in quadruplicate and 
where the first measurement deviated from subsequent measurements was 
discarded. Data was collected for 20 seconds in 0.039 second intervals. 
 
2.2.2 Temperature Optimum Assays 
Temperature assays were performed on the stopped-flow spectrophotometer 
(Tgk Scientific, UK). MalL at 0.026 mg mL-1 was mixed 1:1 with 2 mM PNG to give 
a final concentration of 0.013 mg mL-1 protein and 1 mM PNG (approximately 
10 X KM for all MalL variants). Temperature control was achieved with a circulating 
water bath connected to the stopped-flow observation cell. Accurate temperature 
measurements were obtained using a thermocouple. Reaction was repeated in 
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quadruplicate with a non-recorded dummy shot between each replicate. Data was 
collected for 20 seconds in 0.039 second intervals. 
 
2.2.3 Data Analysis 
Data was analysed by linear regression for the first 10 seconds of rate data using 
Tgk Scientific Kinetic Studio software. Data analysis and equation fitting was 
performed using GraphPad Prism 8.3.0.  
2.2.3.1 Fitting of MMRT equation 
The temperature independent Δ‡  MMRT equation was fit over a limited 
temperature range which included the highest enzyme rates. The reference 
temperature (T0) was them set as the temperature with the maximum rate minus 
four degrees. Using variables from the temperature independent MMRT equation 
and the T0, the temperature optimum was then calculated using Equation 2.1, 
based on this fit. 
 
Equation 2.1. Calculation of Topt 
"F3 = ΔH5
‡ − Δ‡. "
Δ‡ − 1  
 
The temperature dependant MMRT equation was then fit to the full range of data 
with the reference temperature (T0) set as Topt minus 4 degrees. 
 
2.3 Mutagenesis and cloning 
MalL WT and S536R DNA were provided by E. Prentice. MalL TM and W531A/G 




2.3.1 Mutant specific cloning 
2.3.1.1 MalL TM 
The mutant MalL TM was synthesised using Invitrogen GeneArt Gene Synthesis 
(ThermoFischer Scientific, USA). MalL TM was synthesised in a pMA-T cloning 
vector. The MalL TM gene was isolated from the pMA-T cloning vector by 
restriction enzyme digest (Section 2.3.3) with PstI and NcoI and purified by agarose 
gel electrophoresis (Section 2.3.2). The pPROEX-Htb vector was similarly digested 
and purified. The purified MalL TM gene was ligated (Section 2.3.4) into the 
pPROEX-Htb vector and transformed (Section 2.3.5) into E. coli DH5α.  
2.3.1.2 MalL W531A and W531G 
MalL W531G and W531A were prepared by two-halves PCR mutagenesis, 
comprising of two PCR reactions. The first PCR reactions amplifies the gene in two 
sections introducing the desired mutation in the overlapping region. For each 
mutant a forward and reverse mutagenesis PCR was run. Mutation primers were 
ordered from Integrated DNA Technologies (IDT inc., USA). Reactions consisted of 
4 μL of 5 X HOT FIREPol Master Mix (Solis BioDyne, Estonia), 0.5 μL of each primer 
(10 pmol μL-1), 1 μL of MalL WT pPROEX-Htb template (72 ng μL), made up to 20 μL 
with ultrapure water. 
Primers used are given in Table 2.4 and Table 2.5. Forward mutagenesis used 
forward pPROEX-Htb primers and reverse mutagenesis primers. Reverse 
mutagenesis used reverse pPROEX-Htb primers and forward mutagenesis primers. 
PCR cycling parameters are given in Table 2.6. 
 
Table 2.4. pPROEX-Htb primers 
Primer Sequence (5’ – 3’) 
pPROEX-Htb Fwd AGC GGA TAA CAA TTT CAC ACA GG 




Table 2.5. Mutagenesis Primers for MalL W531G and W531A mutants. Bolded residues 
show the mutation location. 
Primer Sequence (5’ – 3’) 
MalL W531G Fwd CTGATTCATGAACGTGGGAAAGTTCTGATTAGC 
MalL W531G Rev GCTAATCAGAACTTTCCCACGTTCATGAATCAG 
MalL W531A Fwd CTGATTCATGAACGTGCGAAAGTTCTGATTAGC 
MalL W531A Rev GCTAATCAGAACTTTCGCACGTTCATGAATCAG 
 
Table 2.6. PCR cycling parameters for MalL W531G and MalL W531A mutagenesis PCR 
reactions 
Step Temperature (°C) Step Length (Fwd) Step Length (Rev) 
Pre-Denaturation 95 15 minutes 15 minutes 
Denaturation 95 15 seconds 15 seconds 
Annealing 60 45 seconds 45 seconds 
Extension 72 2 minutes 15 seconds 
Post-extension 72 10 minutes 10 minutes 
 
The purity of each PCR was assessed by agarose gel electrophoresis (Section 2.3.2). 
A total of four PCR reactions for each mutagenesis reaction was pooled and 
purified by agarose gel electrophoresis (Section 2.3.2). Forward and reverse 
mutagenesis products were used as templates for a second PCR to produce a 
complete copy of the mutated gene using pPROEX-Htb primers. Reactions 
consisted of 4 μL of 5 X HOT FIREPol Master Mix (Solis BioDyne), 0.5 μL of each 
primer (10 pmol μL-1), 0.3 μM of the forward and reverse mutagenesis PCR 
products, made up to 21 μL with ultrapure water. PCR cycling parameters are the 
same as given for the forward mutagenesis PCR given in Table 2.6 above.  
The PCR products of the gene amplified in two sections were purified from 
solution using the High Pure PCR Product Purification Kit (Roche Diagnostics) and 
purity checked by agarose gel electrophoresis (Section 2.3.2). The subsequent 
joining PCR product was purified by agarose gel electrophoresis (Section 2.3.2). 
Purified products were used as template for an additional PCR to further amplify 
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products. Reactions consisted of 20 μL of 5 X HOT FIREPol Master Mix 
(Solis BioDyne), 2.5 μL of each primer (10 pmol μL-1), 13.5 μL of W531G join PCR 
product (24.4 ng μL) or W531A join PCR product (32.6 ng μL-1), made up to 100 μL 
with ultrapure water. PCR cycling parameters were the same as given for the 
forward mutagenesis PCR given in Table 2.6.  
PCR products were purified from solution using the High Pure PCR Product 
Purification Kit (Roche Diagnostics) and purity checked by agarose gel 
electrophoresis (Section 2.3.2). The W531A and W531G genes were digested 
(Section 2.3.3) with PstI and NcoI and purified by agarose gel electrophoresis 
(Section 2.3.2). The pPROEX-Htb vector was similarly digested and purified. The 
purified MalL W531G and W531 A genes were ligated (Section 2.3.4) into the 
pPROEX-Htb vector and transformed (Section 2.3.5) into E. coli DH5α. 
 
2.3.2 Agarose gel electrophoresis 
Agarose gels were made up as required to between 0.8 – 2.0% w/v agarose in TAE 
buffer (40 mM Tris-acetate, 1 mM EDTA). Invitrogen SYBER safe at a final 1 X 
concentration (ThermoFischer Scientific, USA; 10000 X) was added to allow for 
DNA visualisation. Samples were loaded with 5 X DNA loading dye 
[25% v/v glycerol, 0.2% w/v bromophenol blue]. Samples were visualised under 
blue light. Sizes were analysed by comparison to the Invitrogen 1 Kb Plus DNA 
ladder (ThermoFischer Scientific, USA). Gel images were collected using the 
Omega Lum G gel imaging system (Aplegen, USA) and processed using 
RawTherapee 5.7 and Microsoft PowerPoint. 
2.3.2.1 Purification from agarose gel 
Relevant bands were excised from the agarose gel by visualisation under blue light. 
DNA was purified from the agarose gel using either the QIAquick Gel Extraction Kit 
(QIAGEN, Germany) or the UltraClean 15 DNA Purification Kit 
(MO BIO Laboratories, USA) according to the manufacturer’s instructions. DNA 
was eluted into between 15 and 50 μL of elution buffer. 
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2.3.3 Restriction Enzyme Digests 
Restriction enzyme digests were performed using the NEB Cutsmart system 
(New England Biolabs, USA). All digests performed utilised NEB PstI-HF and 
NcoI-HF (20000 U mL-1) restriction enzymes. Digests were performed with 
2000-3000 ng DNA, 60 U of each restriction enzyme and the appropriate amount 
of 10 X Cutsmart buffer in a final reaction volume of 50 μL. Digest reactions were 
left at 37°C for 2 hours. Non-target DNA from the restriction digests was separated 
by agarose gel electrophoresis (Section 2.3.2) and target DNA was purified from 
the gel (Section 2.3.2.1). 
 
2.3.4 Ligations 
Ligation reactions were performed using NEB T4 DNA ligase (400000 U mL-1) 
(New England Biolabs, USA). Ligation reactions were done with a molar insert to 
vector ratio of between 2:1 and 3:1. Reactions were left at 4°C for 20 minutes and 
16°C for 2 hours.  
 
2.3.5 Transformation of E. coli by heat shock 
Plasmids were transformed into chemically competent E. coli DH5α cells by heat 
shock. Chemically competent cells were defrosted on ice. The ligation reaction 
(10 μL) was added to chemically competent cells (100 μL) and incubated on ice for 
30 minutes. Cells were heat shocked at 42°C for 45 seconds and then incubated 
on ice for a further 2 minutes. One millilitre of SOC media [20 g L-1 tryptone, 
5 g L-1 yeast extract, 585 mg L-1 NaCl, 186 mg L-1 KCl, 2.46 g L-1 MgSO4.7H2O, 
2.03 g L-1 MgCl2.6H2O, 20 mM glucose (sterile filtered)] was added and the cells 
were incubated at 37°C for 60 minutes. Aliquots of transformed cells were plated 
on LB Agar plates with 0.1 mg mL-1 ampicillin. Colonies were screened for 




2.3.6 Colony PCR 
Transformation colonies were screened for successful insert by PCR using 
pPROEX-Htb primers (Table 2.4) flanking the gene insert position. Single colonies 
were picked from a plate using a sterile pipette tip, streaked onto an LB agar plate 
containing 0.1 mg mL-1 ampicillin for preservation and then the cell remnants were 
resuspended in the PCR reaction mixture for use as template DNA. PCR reactions 
were set up for each colony using either HOT FIREPol (SolisBioDyne, Estonia) or 
Invitrogen Taq Polymerase (ThermoFischer Scientific, USA). PCR results were 
assessed by agarose gel electrophoresis (Section 2.3.2). Reactions consisted of 
4 μL of 5 X HOT FIREPol Master Mix (Solis BioDyne, Estonia), 0.5 μL of each primer 
(10 pmol μL-1), made up to 20 μL with ultrapure water for HOT FIREPol. 
Composition of Taq PCR reactions is given in Table 2.7. PCR cycling conditions are 
given in Table 2.8. 
 
Table 2.7. Colony PCR composition for Taq polymerase 
Component Volume Final Concentration 
10 X PCR buffer 2.5 μL 1 X 
50 mM MgCl2 0.5 μL 1 mM 
10 mM dNTPs 0.5 μL 0.2 mM 
pPROEX-Htb Fwd primer (10 pmol μL-1) 0.75 μL 0.3 μM 
pPROEX-Htb Rev primer (10 pmol μL-1) 0.75 μL 0.3 μM 
Taq polymerase (5 U μL-1) 0.25 μL 1.25 U 




Table 2.8. PCR cycling parameters for colony PCR reactions 
 HOT FIREPol Taq polymerase 
Step Temperature Step Length Temperature Step Length 
Pre-Denaturation 95 15 minutes 94 2:45 minutes 
Denaturation 95 15 seconds 94 15 seconds 
Annealing 60 45 seconds 58 30 seconds 
Extension 72 2 minutes 72 2 minutes 
Post-extension 72 10 minutes 72 7 minutes 
 
The LB agar plate with colonies selected for colony PCR was incubated overnight 
at 37°C. Colonies with a successful gene insert were picked from the fresh plate 
and grown overnight in 5.5 mL LB media with 0.1 mg mL-1 ampicillin. Plasmid DNA 
was isolated from 5 mL of this culture (Section 2.3.7.2) and sent for sequencing to 
confirm mutation and gene integrity (Section 2.3.8). The remaining 0.5 mL was 
used to create a glycerol stock (Section 2.1.2.1). 
 
2.3.7 DNA purification 
2.3.7.1 Purification from PCR 
Purification of DNA from PCR solution was achieved using the High Pure PCR 
Product Purification Kit (Roche Diagnostics, USA) according to the manufacturer’s 
instructions. Where significant non-target products were observed DNA was 
additionally purified on by separation on agarose gel (Section 2.3.2).  
2.3.7.2 Plasmid purification 
E. coli DH5α (from glycerol stock or transformation plate) containing the relevant 
plasmid was grown overnight in LB media (5 mL) containing 0.1 mg mL-1 ampicillin. 
Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (QIAGEN, Germany) 
according to the manufacturer’s instructions. Plasmid DNA was eluted into 30 μL 





Plasmid DNA was extracted (Section 2.3.7.2) and sent to the Massey Genome 
Sequencing Service with samples prepared with pPROEX-Htb forward and reverse 
primers (Table 2.4)] according to the sample guidelines. 
 
2.4 Crystallisation 
Protein was expressed and purified as described in section 2.1 and concentrated 
to between 8 and 12 mg mL-1. MalL S536R was concentrated to 10 mg mL-1. MalL 
triple mutant (TM) was concentrated to between 8 and 12 mg mL-1. The final 
successful crystallisation concentration for MalL TM was 12 mg mL-1. 
 
2.4.1 Initial crystallisation condition screening 
Initial crystallisation conditions were determined using the sitting drop method. 
Pre-prepared crystal screens (Crystal Screen HT-HR2-130, Index-HR2-144, 
PEGRx HT-HR2-130, SaltRx-HR2-136) from Hampton Research were used as 
precipitant solutions (The salt screen was omitted from the MalL TM crystallisation 
screen due to limited protein). Aliquots of 100 μL of precipitant solution were 
pipetted into 96-well Intelli-Plate 96-2 Low Profile crystallisation plates 
(Hampton research, USA). The Mosquito crystallisation robot (TTP LabTech Ltd, UK) 
was used to dispense 200 nL crystallisation drops consisting 1:1 of protein to 
precipitant solution. Trays were sealed with Crystal Clear Sealing Film 
(Hampton Research, USA) and left at 18°C. 
 
2.4.2 Fine screening of crystallisation conditions 
Initial conditions identified were further refined by using a hanging-drop vapour 
diffusion technique. Conditions were varied from the initial conditions by altering 
pH, precipitant concentration, ionic strength and hanging-drop size. Drop sizes of 
between 1 and 4 μL with varying ratios of protein to precipitant solution were 
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suspended above 500 μL of precipitant solution on a 24 well VDX plate (Hampton 
Research). Wells were sealed with Glisseal N grease (Borer chemie, Switzerland) 
and left at 18°C. 
 
2.4.3 Final crystallisation conditions 
2.4.3.1 MalL S536R 
Final crystallisation conditions for MalL S536R were 0.1 M Tris pH 8.0, 0.2 M 
ammonium acetate and 18% w/v PEG 10,000. Protein concentration was 
10 mg mL-1 and drop size was 4 μL with a 1:1 ratio of protein to precipitant solution.  
2.4.3.2 MalL triple mutant (TM) 
Final crystallisation conditions for MalL TM were 0.1 M Tris HCl pH 8.5, 0.22 M 
Sodium Acetate, 27% w/v PEG 4,000. Protein concentration was 12 mg mL-1 and 
drop size was 3 μL consisting of 2 μL precipitant solution and 1 μL protein. 
 
2.4.4 Data Collection 
2.4.4.1 Crystal preparation 
Crystals were removed from crystallisation drops with a cryo-loop 
(Hampton Research, USA) and transferred to a cryoprotectant solution. 
Cryoprotectant for MalL S536R was 0.1M Tris pH 8.0, 0.2 M ammonium acetate 
and 17% w/v PEG 10,000 with 20% v/v glycerol. Cryoprotectant for MalL TM was 
the same composition as the crystallisation precipitant solution with 20% v/v 
glycerol. Crystals were then frozen in liquid nitrogen for data collection. 
2.4.4.2 Data collection 
X-ray diffraction data was collected on the MX2 beamline at the Australian 





2.4.5 Data Processing 
2.4.5.1 Indexing and integration 
Data was indexed, integrated and scaled using XDS (Kabsch, 2010). Unit cell 
parameters and space group were determined using Pointless (Evans, 2011). 
2.4.5.2 Scaling 
Data was scaled and merged in AIMLESS (Evans & Murshudov, 2013) within the 
CCP4 software suite (Winn et al., 2011). Data was examined and rescaled to 
optimise I/σI to approximately 2 in the outer resolution shell. 
2.4.5.3 Matthews coefficient 
The number of molecules in the asymmetric unit was calculated using the 
Matthews coefficient (Kantardjieff & Rupp, 2003; Matthews, 1968) within the 
CCP4 software suite (Winn et al., 2011). 
2.4.5.4 Molecular replacement 
Molecular replacement was performed using the previously solved apo MalL WT 
structure (PDB: 4M56) for both the MalL S536R and MalL TM datasets. Molecular 
replacement for MalL S536R was performed using Molrep (Vagin & Teplyakov, 
1997) in the CCP4 software suite (Winn et al., 2011). Molecular replacement for 
MalL TM was performed using PHASER (McCoy et al., 2007) in the PHENIX 
software suite (Adams et al., 2010). 
 
2.4.6 Model refinement 
The structure was refined manually in COOT (Emsley et al., 2010) with the 2FO-FC 
electron density map contoured to 1 σ. Model refinement was completed in 
phenix.refine (Afonine et al., 2012) in the PHENIX software suite or Refmac5 




2.4.7 Structure analysis and visualisation 
B-factors were calculated using Baverage (Dodson, 1991) within CCP4. Root Mean 
Square Deviation (RMSD) values were calculated using porSMART (Nicholls et al., 
2014). Pymol (Schrödinger, 2000) was used for visualisation of structures and to 
generate images. 
 
2.5 Normal mode analysis 
Normal mode analysis to predict protein stability changes was performed using 
the Dynamut web server using the C-alpha force field (Rodrigues et al., 2018). 
 
2.6 Figures 
Figures were made using  Gravit Designer (Corel Corporation, 2019), Microsoft 




3 Mutation of MalL to mimic urea binding and 
demonstrate allostery 
3.1 Introduction 
Although allostery has been described in the literature for many years, the precise 
physical mechanisms by which allostery acts is not fully understood. The research 
presented here aims to apply macromolecular rate theory (MMRT) to describe a 
potential mechanism for allosteric action. 
MMRT describes the response of enzymatic rate to temperature and adds the 
change in heat capacity (Δ‡) as a variable of enzymatic rate (Hobbs et al., 2013). 
An enzymes’ heat capacity is mainly described by the number and energy of 
vibrational modes of the molecule. Using this relationship, we can say that 
changes in heat capacity will directly relate to changes in energies of the 
vibrational modes of the enzyme, which in turn may relate to the enzyme rate. It 
has been well noted that enzymes often become more rigid in their ligand bound 
states accompanied by a shift in the vibrational modes to higher frequencies and 
therefore a change in heat capacity, termed Δ  (Arcus et al., 2016). This 
therefore presents a potential mechanism by which ligand binding can alter 
enzymatic rate through changes in Δ‡. We thus sought to explore the role of Δ‡ 
changes in allosteric regulation. 
Allosteric regulation was explored by characterising the kinetics of the enzyme 
isomaltase (MalL). Previous work (unpublished) has characterised the effect of 
non-denaturing (or low) concentrations of urea on the rate of MalL across a range 





Figure 3.1. The temperature optima for MalL is decreased with increasing amounts of 
urea added to the kinetic assay (unpublished). The solid line represents the fit of the 
MMRT equation. 
 
An obvious outcome of these experiments was that the temperature optima for 
MalL decreased in increasing amount of urea. Varying the concentration of urea 
also altered the dynamics of MalL activity across the temperature range, which 
was apparent after fitting the MMRT equation to the data. Interestingly at 1.5 M 
urea concentration, urea acted as a rate activator at low temperatures and a rate 
inhibitor at high temperatures. To probe the structural effects of urea binding on 
enzyme rate, MalL was crystallised, and the structure solved with varying 
concentrations of urea (unpublished). Interestingly, these structure results 




Figure 3.2. Structure of MalL crystallised with 1.5 M urea revealed a binding pocket in 
the C-terminal domain. Residues S536 and E554 with urea bound are shown as sticks 
(unpublished). 
 
Based on the resulting crystal structures of urea bound to MalL, computational 
protein design (Section 1.3.2.2) was used by our collaborators at the Institute for 
Protein Innovation (Harvard) with the aim of designing an engineered version of 
MalL that would replicate the altered kinetics seen previously by the addition of 
urea. This computational technique resulted in the design of two MalL mutants 
where the enzyme was mutated to mimic the effect of urea binding. The two 
mutants developed comprised a single mutant where serine 536 was changed to 
an arginine (S536R) and a triple mutant where the aforementioned serine 536 was 




3.2 MalL Wildtype (WT) 
MalL WT was characterised as a baseline for comparison with all subsequent 
mutants and to ensure experimental conditions are appropriate. 
 
3.2.1 Expression trials of MalL WT 
MalL WT was expressed and purified using established protocols for MalL 
(Section 2.1) [Adapted from Schönert et al. (1998)]. MalL WT was expressed under 
the control of the lac operon in the pPROEX-Htb expression vector in E. coli DH5α. 
Pure soluble protein was obtained by immobilised metal affinity chromatography 
(IMAC) and size exclusion chromatography (SEC). Purity was confirmed by 
polyacrylamide gel electrophoresis (PAGE) (Section 2.1.4) (Figure 3.3). 
 
 
Figure 3.3. Ni IMAC purification of MalL WT. A) Elution chromatogram of MalL WT from 
IMAC column. B) PAGE of IMAC purification of MalL WT. P = Insoluble pellet, S = 
Supernatant containing protein loaded onto column, F = Flow-through of column minus 
bound target protein. Arrow indicates target protein. 
 
MalL WT eluted from the IMAC column as a single peak at approximately 25% 
elution buffer. SDS-PAGE of fractions from under the peak indicates that it 
contained a mixed population of protein with MalL being the major constituent at 
approximately 90%. An intense band between 50 and 75 kDa is consistent with the 
expected MalL size of 69.5 kDa. MalL was further purified by SEC. MalL was eluted 
between 65 and 80 mL with improved purity. This corresponds to an estimated 
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molecular weight of 69.5 kDa which indicates MalL was purified as a soluble 
monomer. Purity was confirmed by SDS-PAGE (Figure 3.4). 
 
 
Figure 3.4. SEC purification of MalL WT. A) Elution chromatogram of MalL WT from SEC 
column. B) PAGE of SEC purification of MalL WT. O = Overflow from ladder well. Arrow 
indicates target protein. 
 
3.2.2 Characterisation of MalL WT 
Kinetic assays were performed based on established protocols for MalL 
(Section 2.2) with the substrate p-nitrophenyl-α-D-glucopyranoside (PNG). 
3.2.2.1 Michaelis-Menten kinetics 
MalL WT was characterised using the Michaelis-Menten kinetic model, to find the 
kcat, KM, and Ki (Figure 3.5). MalL was assayed at 25°C and this temperature was 





Figure 3.5. Michaelis-Menten kinetics of MalL WT at 25°C with the substrate p-
nitrophenyl-α-D-glucopyranoside (PNG). Data fit with substrate-inhibition model. Points 
are averages of triplicate values. Error bars where visible are the standard deviation of 
three replicates. 
 
Michaelis-Menten parameters are given in Table 3.1. Data was fit with a substrate 
inhibition model with a Ki of 11.5 ± 1.8 mM. MalL was found to have a KM of 
0.0817 ± 0.005 mM. Subsequent assays were performed at approximately 10 X KM 
at 1 mM substrate. 
 
Table 3.1. Michaelis-Menten constants for MalL WT 
 Enzyme 
Parameter MalL WT 
kcat (sec-1) 27.1 ± 0.6 
KM (mM) 0.0817 ± 0.005 




3.2.2.2 Temperature characterisation of MalL WT 
The effect of temperature on the rate of MalL WT was assayed as described in 
section 2.2.2 and the data was fitted with a temperature dependant Δ‡ MMRT 
equation (Figure 3.6). 
 
 
Figure 3.6. Results of temperature characterisation of MalL WT fit to the MMRT 
equation with a temperature dependant ΔCP‡. Points are averages of triplicate values. 
Error bars where visible are the standard deviation of three replicates. 
 
Results from the data from MalL WT are shown in Table 3.2. Results are consistent 
with an MMRT fit (R2 = 0.9976). The optimum temperature (Topt) and the heat 
capacity value (Δ‡) are of primary interest in the context of this study, however 
other variables such as T0 (the reference temperature) are integral in 
implementing this equation. The change in enthalpy (ΔH‡) and entropy (ΔS‡) and 
the A value (the relationship of Δ‡  with temperature) are also variables of 
interest. MalL WT has a temperature optimum of 313.4 K (40.4°C). The heat 




Table 3.2. Parameters from the MMRT model fit to MalL WT data 
 Enzyme 
Parameter MalL WT 
T0 (K) 309.4 
ΔH‡ (T0) (kJ mol-1) 42.9 ± 1.2 
ΔS‡ (T0) (J mol-1 K-1) -70.7 ± 3.7 
ΔCP‡ (T0) (kJ mol-1 K-1) -8.5 ± 0.3 
A (kJ mol-1 K-2) -219 ± 15 





3.3 MalL S536R 
Based on computational protein design the MalL mutant MalL S536R was 
proposed (Figure 3.7). MalL S536R is designed to mimic the effect of urea binding 
in the C-terminal domain by placing the side chain group of the introduced 
arginine into the binding pocket of urea. 
 
 
Figure 3.7. Position of S536R mutation in the MalL WT enzyme [PDB 5WCZ (van der 
Kamp et al., 2018)]. Mutated residue (S536) is shown as red spheres. Substrate analogue 




3.3.1 Expression trials of MalL S536R 
Mutagenesis and cloning of the single mutant S536R was performed by E. Prentice 
using established “two-halves PCR” protocols. MalL S536R was expressed and 
purified according to established protocols for MalL variants (Section 2.1). Soluble 
protein was obtained by purification by immobilised metal ion affinity 
chromatography (IMAC) and size exclusion chromatography (SEC) with purity 
confirmed by polyacrylamide gel electrophoresis (PAGE). 
 
 
Figure 3.8. Purification of MalL S536R. A) Ni IMAC elution chromatogram. B) SEC elution 
chromatogram. 
 
MalL S536R eluted from the IMAC column as a single peak at approximately 25% 
elution buffer. The peak contained MalL protein at approximately 90% purity as 
assessed by PAGE (gel not shown). MalL S536R was further purified by SEC. MalL 
S536R eluted from the column between 60 and 80 mL which corresponded to a 
molecular weight of 69.5 kDa in agreement with the purification of a soluble 






3.3.2 Characterisation of MalL S536R 
MalL S536R was assayed based on established protocols for MalL variants 
(Section 2.2) using the substrate p-nitrophenyl-α-D-glucopyranoside (PNG). 
3.3.2.1 Michaelis-Menten kinetics 
The Michaelis-Menten kinetic model was used to find the kcat, KM and Ki for MalL 
S536R (Figure 3.9). 
 
 
Figure 3.9. Michaelis-Menten kinetics of MalL S536R at 25°C with the substrate PNG (p-
nitrophenyl-α-D-glucopyranoside). Data fit with substrate inhibition model. Points are 
averages of triplicate values. Error bars where visible are the standard deviation of three 
replicates. 
 
The results show that MalL S536R has a kcat of 25.5 ± 0.5 sec-1 which is slightly less 
than that of the WT at 27.1 ± 0.6 sec-1 (Table 3.2). MalL S536R also shows more 
significant substrate inhibition compared to the WT as evidenced by its lower Ki 
value. Likewise, the KM of S536R is slightly higher compared to the wildtype 




Table 3.3. Michaelis-Menten constants for MalL S536R compared with MalL WT 
 Enzyme 
Parameter MalL WT MalL S536R 
kcat (sec-1) 27.1 ± 0.6 25.5 ± 0.5 
KM (mM) 0.0817 ± 0.005 0.101 ± 0.006 
Ki (mM) 11.5 ± 1.8 8.7 ± 1.0 
 
3.3.2.2 Temperature characterisation of MalL S536R 
The response of MalL S536R to temperature was measured as described in 
section 2.2.2. The data was fitted with a temperature dependant Δ‡  MMRT 
equation (Figure 3.10). 
 
 
Figure 3.10. Temperature characterisation of MalL S536R fit with the temperature 
dependant ΔCP‡MMRT equation. Points are averages of triplicate values. Error bars 
where visible are the standard deviation of three replicates. 
 
MalL S536R shows a curved temperature dependence consistent with an MMRT 
model (R2 = 0.9979) and has an increased temperature optimum of 316.8 K 
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(43.7 °C). Compared with WT, MalL S536R shows a significant drop in the rate 
across a range of temperatures when compared to the WT enzyme (Figure 3.11).  
 
 
Figure 3.11. Temperature characterisation of MalL S536R versus MalL WT fit with the 
temperature dependant ΔCP‡MMRT equation. 
 
MMRT fit parameters from the temperature characterisation data are shown in 
Table 3.4. Along with a drop in rate across a range of temperatures, MalL S536R 
also shows a significant increase in Δ‡  (-7.4 ± 0.2 kJ mol-1 K-1) (T0 = 312.8 K) 




Table 3.4. MMRT fit parameters of MalL S536R and MalL WT 
 Enzyme 
Parameter MalL WT MalL S536R 
T0 (K) 309.4 312.8 
ΔH‡ (T0) (kJ mol-1) 42.9 ± 1.2 21.4 ± 0.8 
ΔS‡ (T0) (J mol-1 K-1) -70.7 ± 3.7 -145.1 ± 2.5 
ΔCP‡ (T0) (kJ mol-1 K-1) -8.5 ± 0.3 -7.4 ± 0.2 
A (kJ mol-1 K-2) -219 ± 15 -139 ± 9 
Topt (K) 313.4 316.8 
 
3.3.2.3 Characterisation of MalL WT with guanidinium hydrochloride 
Urea has been shown to dynamically effect the enzymatic rate of MalL 
(Section 3.1). Similar dynamic effects were observed in the MalL S536R mutant 
which mimicked the urea binding. We sought to replicate the effects of urea with 
another denaturant, guanidinium hydrochloride. Urea, arginine and guanidinium 
share similar functional groups (Figure 3.12).  
 
 
Figure 3.12. Similarity in functional groups of urea, arginine and guanidinium (Left to 
right, respectively). 
 
MalL WT was assayed for temperature dependence with the addition of 
guanidinium hydrochloride (GuHCl) based on a protocol used by Parker et al., 
(1995). In their study, the N-terminal domain of phosphoglycerate kinase showed 
unfolding between 0.8 and 1.2 M GuHCl (Parker et al., 1995). MalL was therefore 
assayed with 1 M GuHCl as an initial assay concentration, however at this 
concentration MalL activity was found to be completely abolished. The assay was 
then repeated with 0.1 M GuHCl initially over a small temperature range (Figure 
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Figure 3.13. Initial narrow temperature range characterisation of MalL WT with 0.1M 
GuHCl fit with the MMRT equation using a temperature dependent ΔCP‡. Points are 




Figure 3.14. Temperature characterisation of MalL WT with 0.1M GuHCl fit with the 
MMRT equation using a temperature dependent ΔCP‡. Points are averages of triplicate 
values. Error bars where visible are the standard deviation of three replicates. 
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The results from these assays show that GuHCl appears to have little effect on the 
rate of MalL until approximately 303 K (30°C) where it deviates from the WT 
curvature, resulting in a lowered temperature optimum of 309.7 K (36.6°C). The 
Δ‡ is unchanged with the addition of GuHCl at -8.5 ± 0.2 kJ mol-1 K-1 (T0 = 305.7 K), 
compared to -8.5 ± 0.3 kJ mol-1 K-1 (T0 = 309.4 K) without GuHCl (Table 3.5).  
 
Table 3.5. MMRT fit parameters of MalL WT with GuHCl 
 Enzyme 
Parameter 0 M GuHCl 0.1 M GuHCl 
T0  (K) 309.4 305.7 
ΔH‡ (T0) (kJ mol-1) 42.9 ± 1.2 38.3 ± 1.0 
ΔS‡ (T0) (J mol-1 K-1) -70.7 ± 3.7 -87.7 ± 3.4 
ΔCP‡ (T0) (kJ mol-1 K-1) -8.5 ± 0.3 -8.5 ± 0.2 
A (kJ mol-1 K-2) -219 ± 15 -211 ± 13 
Topt (K) 313.4 309.7 
 
3.4 MalL Triple Mutant 
3.4.1 Cloning of MalL triple mutant 
The MalL triple mutant (TM) was designed to mimic the effect of urea binding in 
the C-terminal domain. The MalL TM gene construct was ordered from GeneArt 
(ThermoFisher scientific) codon optimised for E. coli, in the pMA-T cloning vector 
with ampicillin (AMP) resistance. The process of manipulating this construct for 
recombinant protein expression was briefly as follows. MalL TM in pMA-T was 
transformed into E. coli and successful transformants selected by growth on LB 
AMP agar plates. Selected colonies were grown in 5 mL AMP LB cultures to isolate 
plasmid DNA (Section 2.3.7.2). MalL TM was digested from the plasmid 
(Section 2.3.3) and the MalL TM gene (1695 bp) isolated by agarose gel 




Figure 3.15. Restriction enzyme digest of MalL TM from pMA-T cloning vector and digest 
of pPROEX-Htb expression vector. Run on a 1% TAE agarose gel. Bands of interest were 
excised from the gel as shown here. 
 
The MalL TM gene was then ligated into the pPROEX-Htb expression vector 
(Section 2.3.4) and transformed (Section 2.3.5) into E. coli DH5α. Transformed 
E. coli were grown on LB AMP agar plates and selected colonies screened for the 





Figure 3.16. Agarose gel products of a colony PCR of the MalL TM gene. Eight colonies 
were selected from the transformation of MalL TM into E. coli. Run on a 1% TAE agarose 
gel. 
 
All colonies had the expected insert size. Two colonies were selected and sent for 
sequencing (Section 2.3.8). Sequencing results showed both colonies contained 
intact inserts of MalL TM. MalL TM with the mutations (S536D, E554Q, V556R) is 
shown in Figure 3.17. 
 
 
Figure 3.17. Sequencing results of MalL TM shows successful insert of gene construct. 
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3.4.2 Expression trials of MalL triple mutant 
MalL TM was expressed and purified according to established protocols for MalL 
variants (Section 2.1). MalL TM was expressed in E. coli in the pRPOEX-Htb 
expression vector and induced by IPTG induction. Soluble protein was obtained by 
purification by immobilised metal ion affinity chromatography (IMAC) (Figure 3.18) 
and its purity confirmed by polyacrylamide gel electrophoresis (PAGE). Further 
protein purity was achieved by size exclusion chromatography (SEC) (Figure 3.19). 
 
 
Figure 3.18. Ni IMAC Purification of MalL TM. A) Elution chromatogram of MalL TM. B) 
PAGE gel of MalL TM IMAC purification. P = Insoluble pellet, S = Supernatant containing 
protein loaded onto column, F = Flow-through from column minus bound target protein. 
Arrow indicates target protein. 
 
MalL TM was eluted as a single peak at approximately 20% elution buffer from the 
Ni IMAC column. The peak had a majority population of MalL identified by 
denaturing PAGE. PAGE showed an intense band between 50 and 75 kDa 
corresponding to the expected MalL size of 69.5 kDa (as shown by the arrow). MalL 
TM was additionally purified by SEC with improved purity confirmed by PAGE. 
MalL TM eluted between 60 and 80 mL which corresponds to a molecular weight 





Figure 3.19. SEC purification of MalL TM. A) Chromatogram of MalL TM SEC elution. B) 
PAGE gel of MalL TM SEC purification. Arrow indicates target protein. 
 
3.4.3 Characterisation of MalL triple mutant 
Kinetic assays were performed using established protocols for MalL variants 
(Section 2.2) using the substrate p-nitrophenyl-α-D-glucopyranoside (PNG). 
3.4.3.1 Michaelis-Menten kinetics 
The Michaelis-Menten kinetic model was used to find the kcat, KM, and Ki for MalL 
TM. The results are shown in Figure 1.21. 
 
 
Figure 3.20. Michaelis-Menten kinetics of MalL TM. Data is fitted with a substrate 
inhibition model. Substrate p-nitrophenyl-α-D-glucopyranoside (PNG). Points are 




MalL TM has a kcat of 34.3 ± 1.0 sec-1 and a KM of 0.124 ± 0.009 mM which are both 
higher than MalL WT at 27.1 ± 0.6 sec-1 and 0.0817 ± 0.005 mM, respectively 
(Table 3.6). Substrate inhibition is much more pronounced in MalL TM than WT 
with a Ki of only 3.4 ± 0.3 mM compared with 11.5 ± 1.8 mM (Figure 3.21). 
 
Table 3.6. Michaelis-Menten constants for MalL TM compared with MalL WT. 
 Enzyme 
Parameter MalL WT MalL TM 
kcat (sec-1) 27.1 ± 0.6 34.3 ± 1.0 
KM (mM) 0.0817 ± 0.005 0.124 ± 0.009 
Ki (mM) 11.5 ± 1.8 3.4 ± 0.3 
 
 
Figure 3.21. Michaelis-Menten kinetics of MalL TM versus MalL WT. 
 
3.4.3.2 Temperature characterisation of MalL triple mutant 
The activity of MalL TM was assayed with temperature using normal protocols for 
MalL (Section 2.2.2). Data was fitted to a temperature dependent Δ‡  MMRT 




Figure 3.22. Temperature characterisation of MalL TM fit with the temperature 
dependant ΔCP‡ MMRT model. Points are averages of triplicate values. Error bars where 
visible are the standard deviation of three replicates. 
 
MalL TM shows a curved temperature dependence consistent with MMRT 
(R2 = 0.9996). MalL TM has a temperature optimum of 313.1 K (40°C) which is 
almost identical to MalL WT. MalL TM shows a reasonably similar temperature 
profile to that of the WT enzyme (Figure 3.23), however it has a slightly higher rate 
overall with a Δ‡ of -9.3 ± 0.1 (T0 = 309.1 K), which is slightly lower than that of 





Figure 3.23. Temperature characterisation of MalL TM versus WT fit with the 
temperature dependant ΔCP‡ MMRT model. 
 
Table 3.7. MMRT fit parameters of MalL TM and MalL WT 
 Enzyme 
Parameter MalL WT MalL TM 
T0  (K) 309.4 309.1 
ΔH‡ (T0) (kJ mol-1) 42.9 ± 1.2 44.9 ± 0.4 
ΔS‡ (T0) (J mol-1 K-1) -70.7 ± 3.7 -62.1 ± 1.4 
ΔCP‡ (T0) (kJ mol-1 K-1) -8.5 ± 0.3 -9.3 ± 0.1 
A (kJ mol-1 K-2) -218 ± 15 -229 ± 6 
Topt (K) 313.4 313.1 
 
3.5 Discussion 
MalL and its variants have provided the platform to explore the effects of allostery. 
We have successfully shown that mutations far away from the active site can have 
significant effects on enzymatic rates, via changes in enzyme dynamics.  
MalL S536R achieved a significant decrease in the rate over the WT enzyme with 
a kcat of 25.5 ± 0.5 sec-1 compared to WT at 27.1 ± 0.6 sec-1 at 25°C. The S536R 
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variant resulted in an increased temperature optimum and  Δ‡ compared to the 
WT enzyme, with a Topt of 316.8 K (43.7 °C) and a Δ‡  of -7.4 ± 0.2 kJ mol-1 
(T0 = 312.8 K) compared to a Topt of 313.4 K (38.3°C) and a Δ‡ -8.5 ± 0.3 kJ mol-1 
(T0 = 309.4 K) in MalL WT. This is consistent with a rigidification of the C-terminal 
domain, which is shown by predicted stability changes (calculated by Normal 
Mode Analysis) (Section 2.5), in Figure 3.24 (Rodrigues et al., 2018). 
 
 
Figure 3.24. Predicted dynamic changes in MalL S536R based on normal mode analysis. 
Blue regions are regions of increased rigidity compared to the WT enzyme. 
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MalL S536R was able to exert its effect on the rate from approximately 30 Å away 
from the active site. This shows that allosteric effects can be transmitted across 
domain boundaries to effect catalytic rate via heat capacity changes. The 
Michaelis-Menten kinetics indicate a much subtler effect on the enzymatic rate 
than that observed in the temperature characterisation. We can make use of the 
A value from the MMRT equation, which is the relationship of heat capacity with 
temperature. A large negative number indicates that Δ‡ is negatively correlated 
with an increase in temperature. Interestingly for S536R, the Δ‡ is not as strongly 
correlated with temperature as MalL WT, as the A value is only -139 ± 9 kJ mol-1 K-2 
for S536R compared to -219 ± 15 kJ mol-1 K-2 in WT. This means that as 
temperature increases, the value for Δ‡ for MalL S536R will not decline as much 
as WT, in other words it will remain more rigid.  
Previous research (Hobbs et al., 2013) showed a relationship between two kinetic 
terms, with an increase in Topt correlating to a less negative Δ‡ value. With MalL 
S536R, we have seen results consistent with this; Topt increased and the Δ‡ value 
increased. In other words, the enzyme became less dynamic but was able to 
increase the temperature at which it was optimal. 
Addition of GuHCl was used to mimic the effect of the arginine mutation in the 
C-terminal domain. Although a strong deviation at elevated temperatures was 
observed in the temperature characterisation with the addition of 0.1 M GuHCl, 
overall parameter fit of the MMRT equation is very similar. The Δ‡  with the 
addition of 0.1 M GuHCl [-8.5 ± 0.2 kJ mol-1 K-1 (T0 = 305.7 K)] is within margin of 
error of MalL WT [-8.5 ± 0.3 kJ mol-1 K-1 (T0 = 309.4 K)]. The addition of 0.1 M 
GuHCl produces a similar profile to that of urea with slight activation at low 
temperatures and inhibition at higher temperatures with a decreased Topt. 
MalL TM has both an increased kcat and increased substrate inhibition (lower Ki). 
The Δ‡  in MalL TM has increased compared to the WT enzyme. The Δ‡ 
was -8.5 ± 0.3 kJ mol-1 K-1 (T0 = 309.4 K) in the WT enzyme compared 
to -9.3 ± 0.1 kJ mol-1 K-1 (T0 = 309.1 K) for TM. This seems to indicate that in 
contrast to the S536R mutant the triple mutation has had an overall destabilising 
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effect on the MalL enzyme. The increased rate for this enzyme may have been 
achieved via enzyme-substrate destabilisation.  
Crystal structures of MalL S536R and TM are presented in Section 4. In the future 
these structures would allow for the analysis of heat capacity changes in these 
mutants by molecular dynamics simulations. Molecular dynamics simulations can 
allow for visualisation of molecular motions over time. This allows for observations 
of how flexibility and heat capacity is changing across the enzyme. This would 
allow for a better understanding of how these mutations exert their effects on the 
enzymatic rate. In addition, there is some disagreement between the 
Michaelis-Menten and temperature characterisation that the cause of which 
would need to be resolved. 
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4 Crystal structures of MalL mutants S536R and 
the triple mutant (S536D, E554Q, V556R) 
4.1 Introduction 
The MalL S536R and MalL triple mutant (TM) were created to mimic the effects of 
urea binding in the C-terminal domain of MalL. These two mutants were 
characterised kinetically, and the results showed significant changes to their 
enzymatic rates (Sections 3.3.2 and 3.4.3). Following the kinetic characterisation, 
we sought to crystallise the mutant enzymes in order to characterise them 
structurally. 
 
4.2 MalL S536R crystallisation and structure determination 
4.2.1 Crystallisation 
Initial crystallisation conditions were determined by screening from a library of 
384 crystallisation conditions (Hampton Research) using sitting drop techniques 
(Section 2.4.1). Promising conditions were further screened by using hanging-drop 
techniques by varying ionic strength, pH, precipitant, drop size and protein 
concentration (Section 2.4.2). Final crystallisation conditions for MalL S536R were 
0.1 M Tris pH 8.0, 0.2 M ammonium acetate and 18% w/v PEG 10,000. Protein at 
a concentration of 10 mg.ml-1 was mixed at a 1:1 ratio with precipitant solution. 
 
4.2.2 Data collection 
Crystals were frozen in liquid nitrogen with 20% v/v glycerol added to the 
precipitant solution as a cryoprotectant. Crystals were taken to the Australian 
Synchrotron for data collection. Data were collected at a distance of 125 mm. Data 
were collected for a full 360° rotation in one degree increments for one second 
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Figure 4.1. Representative crystals and X-ray diffraction for MalL S536R. X-ray 
diffraction recorded to 1.1Å. 
 
4.2.3 Data processing 
Data processing was performed in the CCP4 software suite (Winn et al., 2011). 
Space group determination was performed in Pointless (Evans, 2011). Data was 
scaled and merged in AIMLESS (Evans & Murshudov, 2013). Matthews coefficient 
analysis was used to find the number of molecules in the asymmetric unit 
(Kantardjieff & Rupp, 2003; Matthews, 1968). Statistics from these processes is 




Table 4.1. Data collection statistics for MalL S536R. 
Data Statistic MalL S536R 
Space group P 1 21 1 
Wavelength (Å) 0.9537 







Monomers in the asymmetric unit 1 
Resolution range (Å) 23.06-1.10 (1.12-1.10) 
Number of observed reflections 1477816 (65945) 
Number of unique reflections 208284 (9598) 
Rmerge 0.06 (0.51) 
Mean I/σI 15.2 (3.5) 
Completeness 94.1 (87.8) 
Multiplicity 7.1 (6.9) 
Wilson B-factor 9.79 
* Values in brackets correspond to the outer resolution shell. 
 
Molecular replacement using the previously solved MalL WT structure (PDB: 4M56) 
was performed using Molrep (Vagin & Teplyakov, 1997). Models were manually 
refined in COOT (Emsley et al., 2010). Refinement of the model was performed 
using Refmac5 in CCP4 or Phenix (Afonine et al., 2012; Murshudov et al., 1997). A 





Figure 4.2. Representative electron density map and model fit of MalL S536R at 1.10 Å 
resolution. Contour level is set to 1.00 rmsd. 
 
Thirty amino-acids were missing from the N-terminus including the hexa-His tag 
and were not modelled in the final structure (Full length protein sequence is 
included in Section 7.1). A small number of sidechains were unable to be modelled 
into the final density. Three additional molecules were identified in the crystal 
structure. Tris and glycerol from crystallisation conditions and cryoprotectant 
were identified near the active site. A calcium ion was found to be bound to Asp20, 
Asn22, Asp24, Phe26 and Asp28 which is consistent with calcium binding in other 




Table 4.2. Refinement statistics for MalL S563R. 
Refinement statistic MalL S536R 
R-factor 0.127 
R-free 0.145 
Total number of atoms 5209 
Total number of protein atoms 4713 
Other molecules 3 
Number of waters 481 
RMSD: 
Bond length (Å) 











Percentage in favoured regions 
Percentage in allowed regions 






4.3 MalL triple mutant (S536D, E554Q, V556R) crystallisation and 
structure determination 
4.3.1 Crystallisation 
Initial crystallisation conditions were determined by screening from a library of 
288 conditions (Hampton Research) using sitting drop techniques. Promising 
conditions were further screened by using hanging-drop techniques where ionic 
strength, pH, precipitant and protein concentration was varied. Final 
crystallisation conditions for the triple mutant were 0.1 M Tris HCl pH 8.5, 0.22 M 




4.3.2 Data collection 
Crystals were frozen in liquid nitrogen and taken to the Australian synchrotron for 
data collection. Crystals were frozen with 20% v/v glycerol added to the 
precipitant solution as a cryoprotectant. Data was collected for a full 360° rotation 
in one degree per second increments at a detector distance of 225 mm. 
Representative crystals and diffraction for MalL TM is shown in Figure 4.3. 
 
 
Figure 4.3. Representative crystals and X-ray diffraction for MalL TM. X-ray diffraction 
recorded to 1.6 Å. 
 
4.3.3 Data processing 
Data processing was performed using the CCP4 and PHENIX software suites 
(Adams et al., 2010; Winn et al., 2011). Space group determination was done using 
Pointless (Evans, 2011). Data was scaled and merged in AIMLESS (Evans & 
Murshudov, 2013). Data was cut off at this stage to 1.7 Å resolution to make I/σI 
approximately two in the outer resolution shell. Matthews coefficient analysis was 
performed to determine the number of monomers in the asymmetric unit 
(Kantardjieff & Rupp, 2003; Matthews, 1968). Data collection statistics are shown 




Table 4.3. Data Statistics for MalL Triple Mutant. 
Data Statistic MalL TM 
Space group P 1 21 1 
Wavelength (Å) 0.9537 







Monomers in the asymmetric unit 1 
Resolution range (Å) 45.81-1.70 (1.73-1.70) 
Number of observed reflections 360320 (19103) 
Number of unique reflections 52199 (2731) 
Rmerge 0.08 (0.834) 
Mean I/σI 12.5 (2.2) 
Completeness 100 (100) 
Multiplicity 6.9 (7) 
Wilson B-factors 18.857 
* Values in brackets correspond to the outer resolution shell. 
 
Molecular replacement was performed using Phenix (Phaser-MR) using the 
previously solved MalL WT structure (PDB: 4M56) as a model (McCoy et al., 2007). 
Manual model building was performed in COOT (Emsley et al., 2010). Refinement 
was completed using Refmac5 and Phenix (Afonine et al., 2012; Murshudov et al., 





Figure 4.4. Electron density map and model quality fit of MalL TM at 1.7 Å resolution. 
Contour is set to 1.00 rmsd. 
 
There were 29 amino-acids including the hexa-his tag at the C-terminus that were 
not modelled in the final structure (Full length protein sequence is included in 
Section 7.1). A small number of side chains throughout the structure were missing 
from the electron density. Side chains from these residues were not modelled in 
the final structure. Three additional molecules were identified in the crystal 
structure. Tris from the crystallisation conditions and glycerol from the 
cryoprotectant were identified near the active site. A calcium metal ion was 
identified near the C-terminus coordinated with the amino acids Asp20, Asn22, 
Asp24, Phe26 and Asp28. This calcium binding site is consistent with other MalL 
structures, and that of glycoside hydrolase group 13 (GH13) members in general. 




Table 4.4. Refinement statistics for MalL TM. 
Refinement statistic MalL TM 
R-factor 0.152 
R-free 0.188 
Total number of atoms 4910 
Total number of protein atoms 4565 
Other molecules 3 
Number of waters 330 
RMSD: 
Bond length (Å) 











Percentage in favoured regions 
Percentage in allowed regions 







4.4.1 Structural Comparison 
The structures of MalL S536R and MalL TM show the same structural architecture 
as MalL WT, which is also seen in other GH13 enzymes. A comparison of all three 
structures viewed from one aspect highlights their similarity (Figure 4.5). Global 
Root Mean Square Deviation (RMSD) values (Calculated from Cα atoms) between 
MalL variants are between 0.3 and 0.7 Å, indicating a high level of structural 
similarity (Table 4.5). The unit cell parameters of MalL TM were nearly identical to 
that of MalL S536R, however had a 10% decrease in the unit cell size (100.95 to 
89.39 Å). In contrast to the WT structure (PDB: 4M56) both the TM and S536R 
structures contained only one monomer in the asymmetric unit. 
Mutation positions are approximately 30 Å away from the active site as illustrated 
by arrows/dots in the structures below. This means that there is no obvious 
structural change that is responsible for variations in rate. This leads to the 
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conclusion that any changes to the enzymatic rate must have their origins rooted 
in the dynamic activity of the enzyme. 
 
 
Figure 4.5. Structural comparison of different variants of the MalL enzyme. A) MalL WT 
(PDB: 4M56). B) MalL S536R. C) MalL TM (S536D, E554Q, V556R). Catalytic residues 
represented as spheres. Mutations are shown as sticks and indicated with an arrow. 
 
Table 4.5. Root Mean Square Deviation between MalL variants. 
 4M56_A 4M56_B S536R 
S536R 0.325 (555) 0.381 (556) NA 
TM 0.570 (555) 0.695 (556) 0.587 (559) 
*Values in brackets are number of atoms compared 
 
MalL has three domains which are easily identified in the structures above. The 
C-terminal domain C is located at the bottom with the catalytic TIM barrel domain 
A in the centre and the calcium binding domain B at the top. 
Some general structural observations between the variants are as follows. In the 
C-terminal domain, there has been some minor movement in the β-strands which 
alters the distance between the two β-sheets. In the catalytic domain, some 
helices shown on the left side have altered their curvature which creates a slightly 
differently shaped pocket next to the active site. There has been a slight 
movement of the most distal loop in the calcium binding domain. Calcium binding 
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is a general feature of many glycoside hydrolase enzymes. The calcium binding in 
MalL S536R and MalL TM is consistent with the β1-α1 loop calcium binding site 
seen in other GH13 enzymes.  
These combinations of minor structural changes in the MalL mutants are proposed 
to have led to dynamic changes within the enzyme, which has ultimately affected 
catalysis. This is likely to be due to the changes at the amino acid level that have 
transmitted structural perturbations from the site of mutation to the site of 
catalysis. 
4.4.1.1 Comparing mutated residues with urea binding 
The mutations in MalL S536R and MalL TM were designed to mimic the effects of 
urea binding in the C-terminal domain of MalL. In both cases an arginine was 
introduced in a position to occupy the binding site of urea. In the TM mutant two 
additional mutations were introduced in order to provide support to the 
introduced arginine. The crystal structure of both mutants reveal that the 
introduced arginine residue occupies the area that would ordinarily be the binding 
site for urea (Figure 4.6 and Figure 4.7). 
In the single mutant (S536R), the arginine residue protrudes into the space 
between the β-sheets which is the same space occupied by urea (Figure 4.6). 
Examination of the binding interaction of urea in the WT structure shows that urea 
interacts with Ser536 as well as Glu554, which is on the opposite side of the urea 
molecule. In the S536R mutant, the position of Glu554 is unaltered compared to 





Figure 4.6. Cut-away view of an overlay of MalL S536R with MalL WT with urea bound 
in the C-terminal domain. MalL S536R is green with Arg536 and Asp554 shown as sticks; 
MalL WT (with urea bound) is blue with urea and the interacting residues shown as sticks. 
 
In the MalL TM it is also the introduced arginine residue that occupies the same 
space as the urea molecule (in the WT structure) however the arginine comes from 
the adjacent β-strand from the V556R mutation (Figure 4.7). The aspartic acid 
introduced in place of Ser536 does not occupy the urea binding site and the third 





Figure 4.7. Cut-away view of an overlay of MalL TM with MalL WT with urea bound in 
the C-terminal domain. MalL TM is pink with mutated residues shown as sticks; MalL 
WT (with urea bound) is blue with urea and the interacting residues shown as sticks. 
 
4.4.2 B-factor analysis of MalL variants 
B-factors describe the decrease in scattering intensity due to thermal motion. In 
general B-factors can be used as an indicator for the relative vibrational motion of 
atoms contained within a protein, where a low B-factor is indicative of reduced 
motion in a well-ordered site (Sun et al., 2019). B-factor analysis of MalL variants 





Figure 4.8. Average B-factor analysis of MalL variants viewed by their respective 3D 
structures. A) MalL WT, 2.3 Å, B-factor range 11.2 – 89.8. B) MalL S536R, 1.10 Å, B-factor 
range 8.1 – 245.5. C) MalL TM, 1.7 Å, B-factor range 15.2 – 60.6. B-factors shown in scale, 
from low to high (blue-light blue-green-yellow-orange-red). Colours are indicative of 
variation within individual structures only. 
 
Overall, S536R shows a significant reduction in B-factors across the entire enzyme 
compared to WT and TM, except in a few small regions where B-factors are 
significantly higher, due to limitations in model fitting to regions of poor electron 
density. This is consistent with a significant rigidification of the enzyme dynamics 
which is consistent with the observed kinetic data, which showed an increase in 
Δ‡ and an increase in Topt. 
MalL TM in contrast shows a slight rigidification through domain B (residues 
108-171) compared to WT. It also shows a loosening in the second half of the 
enzyme from β-strand 7 which comprises the domain interface between domains 
A and C, as well as through the C-terminal domain. This region also contains an 
α-α extension (residues 390-420) between β8 and α8 of the TIM barrel, which 





Figure 4.9. Substrate binding pocket of MalL TM. Active site residues are shown as 
spheres. Mobile α-α extension is coloured red. Binding pocket is between active site 
residues and α-α extension, indicated by a black arrow. 
 
An alternative way of viewing the B-factor analysis is to graph this variable against 
the individual amino acids (Figure 4.10). With this view, we can compare the MalL 
mutants in a numerical fashion instead of by colour. It becomes obvious that MalL 
S536R has the lowest B-factor throughout the whole protein and the triple mutant 
has B-factors somewhere in between WT and S536R, depending on the area of the 
protein. In fact, for the TM the C-terminal region clearly has a higher B-factor than 
WT, highlighting the dynamic change that has occurred in this β-sheet Greek key 





Figure 4.10. Average B-factor analysis of MalL crystal structures shown across the 
residue range. MalL S536R (Green), MalL TM (Pink), MalL WT Chain A (Dark blue), MalL 
WT Chain B (Light blue). High B-factors on MalL S536R (residues 215-217 and 539-544) 
are caused by limited model fit due to poor electron density in highly mobile regions. 
Asterix represents a specific loop region discussed in section 4.4.3. 
 
4.4.3 Enzyme dynamics of the C-terminal domain 
The C-terminal domain of MalL forms a double antiparallel β-sheet in a Greek key 
motif. This overall structure is consistent between the different MalL mutants. In 
both S536R and TM the mutated residues are located in this C-terminal domain. 
Kinetic data from the S536R and TM mutants show that the interactions in this 
region can have significant effects on the rate and the temperature-dependence 
of the rate. Both mutants are expected to modify enzyme activity by altering the 
dynamics of the enzyme. The S536R and TM mutants are hypothesised to exert 
their effects by rigidifying the C-terminal domain and increasing the flexibility 
respectively. The B-factor analysis does show an increase in flexibility in the 
C-terminal domain of the TM and a decrease in the C-terminal domain of S536R 
(with respect to WT) (Figure 4.11). The interactions of the mutated residues in 





Figure 4.11. Average B-factor analysis of the C-terminal domain of MalL crystal 
structures. MalL S536R (Green), MalL TM (Pink), MalL WT Chain A (Dark blue), MalL WT 
Chain B (Light blue). 
 
 
Figure 4.12. Polar interactions of the mutated MalL residues in the C-terminal domain. 
A) MalL S536R. B) MalL TM. Mutated residues shown as thick sticks and the interacting 
residues shown as thin sticks with yellow dashes as interactions. 
 
The arginine in the S536R mutant interacts with Glu554 and the backbone of 
Arg542, creating a connection between a β-strand on one side and a loop on the 
other side of the Greek key motif. The MalL TM in contrast mainly consists of local 
interactions. Mutated residue S536D interacts with the adjacent Asn537 and 
mutated residue E554Q interacts with Lys551 in the same loop and Val511 in the 
adjacent β-strand. The third mutation (V556R) interacts with the backbone of 
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Ala543 on the opposite loop in a similar way to the arginine in the S536R mutant. 
Overall, it appears that the single S536R mutation has rigidified the C-terminal 
domain by forming a bridge that spans from one side to the other. This is in 
contrast with the TM where the three mutations have allowed for movement to 
translate between them.  
The specific loop region between Asn537 and Lys546 is generally highly mobile in 
MalL structures and poorly defined in the electron density, due to its position as a 
flexible loop on the exterior of the protein. Interestingly in the TM structure this 
region is well defined. In the TM the E554Q and V556R mutations interact with the 
S536D mutation and the backbone of Ala543 in the mobile loop to restrict its 
movement (Figure 4.13). From the illustration of the overlay of the TM with WT 
MalL it is obvious that these three interacting mutated residues have drawn the 
mobile loop in towards the centre of the Greek key motif hence contributing to a 
reduction in movement in this specific area. 
 
 
Figure 4.13. Polar interactions of the mutated MalL residues in the mobile C-terminal 
loop (Asn537-Lys546). A) MalL S536R. B) MalL TM. Mutated residues shown as thick 
sticks and the interacting residues shown as thin sticks with yellow dashes as 




4.4.4 Structural analysis and MMRT 
MalL S536R shows a decrease in flexibility across the whole enzyme consistent 
with the observed increase in Δ‡ . An overall increase in rigidity moves the 
vibrational modes to higher frequencies and results in a lower heat capacity. This 
lowers the difference in heat capacity between the reactant state and the more 
restricted transition state, thus increasing Δ‡. This has also resulted in a lowered 
enzymatic rate as observed with MalL S536R. 
MalL TM shows an overall increase in flexibility compared to the WT enzyme. This 
is reflected in the kinetic data where TM has a lower Δ‡, and a corresponding 
increased rate. MalL TM also contains a more flexible α-α loop that forms part of 
the structure of the substrate binding site. This could possibly be the cause for the 
observed increase in substrate inhibition. Potential mechanisms for substrate 
inhibition, as observed in other glycoside hydrolase enzymes include the 
formation of an Enzyme-Substrate-Substrate complex or a limited turnover 
Substrate-Intermediate complex (Liao et al., 2016). Both of these mechanisms may 
be enhanced by increased permeability of substrate to the binding pocket. At low 





5 Chemical rescue of MalL activity to mimic 
allostery  
5.1 Introduction 
The success of engineering an allosteric mechanism of regulation into previously 
non-allosteric proteins has to date been limited. To date, successful attempts at 
engineering have depended on the modularity of protein domains. This approach 
has utilised naturally occurring allosteric domains and fused them to other 
separate catalytic domains. However, the success of this approach is limited and 
requires screening of multiple domain configurations to find successful 
combinations. Other approaches include designing catalytic activity into an 
allosteric domain however computational restrictions limit the feasibility of this 
approach (Deckert et al., 2012).  
An alternative strategy (instead of altering an allosteric domain for catalysis), is to 
alter a catalytic domain for allosteric control by careful design. One approach to 
achieve this is to design a cavity-forming mutation with the aim of supplementing 
the enzyme with small hydrophobic ligands to occupy the cavity. If a 
cavity-forming mutation can be placed in such a way that catalytic activity is 
affected, then subsequent addition of a small molecule complementary to the 
formed cavity can restore activity. For full restoration of activity, precise rescue of 
structure needs to be achieved (Deckert et al., 2012). This specificity can be 
achieved by muting a scaffolding amino acid such as tryptophan. The cavity can 






Figure 5.1. Cavity forming mutations (for example tryptophan (W) to glycine (G)) can 
alter enzyme structure (red) leading to changed enzyme rates. Structural changes can 
then be rescued by the addition of a chemical mimic of the removed residue. 
 
Deckert and colleagues explored tryptophan mutations as a way to alter active site 
geometry and thus alter enzyme rate (Deckert et al., 2012). Follow up studies also 
indicated that similar tryptophan mutations can alter enzyme rates by alternative 
mechanisms such as enhanced fluctuations (alteration of the conformational 
ensemble) or localised unfolding (Xia et al., 2013). We therefore attempted to 
apply this approach with our own isomaltase model enzyme. The isomaltase 
enzyme (MalL, EC: 3.2.1.10) catalyses the hydrolysis of various disaccharides (such 
as maltose or sucrose) and a range of maltodextrins. MalL consists of two domains, 
an N-terminal catalytic TIM (triosephosphate isomerase) barrel domain and a 
C-terminal all β-strand domain. We intended to replicate the chemical rescue 
technique described above in MalL. A buried tryptophan residue was identified at 
position 531 in the C-terminal β-strand domain for mutagenesis. The C-terminal 
domain has previously been shown in our earlier research to have effects on 
catalytic rate presumably due to dynamic effects (Section 3) and hence was an 
obvious target for mutagenesis. This residue was mutated to glycine and alanine 
and characterised kinetically with and without the addition of indole as a chemical 
rescue agent. The position of the mutated tryptophan residue 531 is shown in 




Figure 5.2. Position of the W531G mutation in wildtype isomaltase enzyme MalL [PDB 
5WCZ (van der Kamp et al., 2018)]. The mutated tryptophan (W531) is shown as red 
spheres in the C-terminal domain. Substrate analogue (1-Deoxynojirimycin) is shown as 





Figure 5.3. Interactions of W531 and G531 in the C-terminal domain of MalL. A) MalL 
W531 (Blue). B) MalL G531 (Blue) 
 
5.2 Mutagenesis and cloning of MalL tryptophan mutants 
5.2.1 Two-halves PCR 
Mutation of tryptophan 531 to either alanine or glycine was achieved using 
two-halves PCR mutagenesis (Section 2.3.1.2). In this method, initially two PCR 
reactions are performed which amplify the gene in two sections, introducing the 
desired mutation in an overlapping region of the two products. A second PCR 
reaction (using the product of the two initial PCR reactions as a template) allows 
the mutated halves to anneal and form a complete mutated gene. Mutation of 
tryptophan 531 generates a forward product 1714 bp long and a reverse product 





Figure 5.4. PCR products of W531G and W531A forward, reverse and joining reactions 
on 2% TAE agarose gel. 
 
Bands of the expected sizes (1714, 171 bp) for the forward and reverse reactions 
could be identified on the agarose gel. The PCR joining reaction however showed 
a major band at the expected size (1852 bp), as well as additional bands 
representing the forward and reverse products that were used as the template 
and other nonspecific bands (Figure 5.4, arrow as an example). Because of this 
result, full length PCR products were separated by agarose gel electrophoresis 
(Section 2.3.2) and the appropriate sized band was excised and purified to isolate 
the complete mutated gene. The mutated gene was then ligated (Section 2.3.4) 
into the pPROEX-Htb expression vector and transformed into the Escherichia coli 
strain DH5α (Section 2.3.5). Transformed colonies were selected by growth on LB 




Figure 5.5. Agarose gel products of a colony PCR of the gene for MalL mutants. Eight 
colonies were selected from each of the transformations of W531A and W531G into E. 
Coli. Products were run on a 1% TAE agarose gel.  
 
Three colonies from each mutation (W531A or W531G) had the expected gene 
insert represented by the 1852 bp band. Colonies containing the gene insert were 
sent for sequencing. Only one sequence for W531G had sufficient quality or lacked 
other mutations to confirm the inserted mutation. Mutation to alanine proved 
problematic as additional mutations were introduced during PCR and therefore it 
was unable to be characterised kinetically. The successful sequencing of MalL 
W531G is shown in Figure 5.6.  
 
 




5.3 Expression trials of MalL W531G 
MalL W531G was expressed and purified using well established protocols for MalL 
variants (Section 2.1). MalL W531G was expressed in E. coli in the pPROEX-Htb 
expression vector under the control of the lac promoter. Protein expression was 
induced by addition of IPTG. Soluble protein was obtained by purification by 
immobilised metal ion affinity chromatography (IMAC) and purity confirmed by 
polyacrylamide gel electrophoresis (PAGE) (Figure 5.7).  
 
 
Figure 5.7. Ni IMAC Purification of MalL W531G A) Chromatogram of MalL W531G Ni 
IMAC purification. B) PAGE gel of MalL W531G Ni IMAC purification. P = Insoluble pellet, 
S = Supernatant containing protein loaded onto column, F = Flow-through of column 
minus bound target protein. Arrow indicates intense band showing purification of target 
protein. 
 
MalL W531G protein eluted from the IMAC column as a single peak at 
approximately 20% elution buffer. This peak contained a mixed population of 
protein with MalL comprising approximately 90% of the total protein as identified 
by SDS-PAGE. An intense band between 50 and 75 kDa (represented by a black 
arrow) corresponded to the expected MalL size of 69.5 kDa. MalL W531G was 
further purified by size exclusion chromatography (SEC) and purity confirmed by 
PAGE. MalL W531G eluted from the SEC column with improved purity between 65 
and 80 mL which is estimated to be a molecular weight of approximately 69.5 kDa 
indicating MalL purified as a soluble monomer (Figure 5.8). A band between 50 




Figure 5.8. PAGE Gels of MalL W531G purification. A) Ni IMAC of MalL W531G. Samples 
A5-13 correspond to a range of fractions over peak B) SEC of MalL W531G. Samples B1-9 
correspond to fractions over peak. Arrow indicates intense band showing purification of 
target protein. 
 
5.4 Characterisation of MalL W531G 
A range of kinetic assays were performed based on established protocols for MalL 
variants (Section 2.2) using the substrate p-nitrophenyl-α-D-glucopyranoside 
(PNG).  
 
5.4.1 Michaelis-Menten Kinetics 
The Michaelis-Menten kinetic model was used to find the kcat, KM and Ki for MalL 
W531G with and without the addition of indole. Two indole concentrations were 
chosen based on previous work by Deckert et al., (2012). Deckert and colleagues 
found that addition of indole at 10 mM showed complete catalytic rescue of the 
enzyme structure (Deckert et al., 2012). Indole concentrations below this value at 





Figure 5.9. Michaelis-Menten kinetics of MalL W531G at 25°C with varying Indole 
effector concentrations. A) 0 mM indole. B) 0.5 mM indole. C) 5 mM indole. Data fit to 
substrate inhibition model. PNG is MalL substrate (para-nitrophenyl-α-D-
glucopyranoside). Points are averages of triplicate values. Error bars where visible are 
the standard deviation of three replicates. 
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The kcat was significantly increased at low indole concentrations (0.5 mM) but 
decreased slightly at high concentrations of indole (5 mM). KM increased with 
indole concentration. At 5 mM indole KM was nearly 35% higher than at 0 mM 
indole. At 0 mM and 0.5 mM indole MalL W531G showed low levels of substrate 
inhibition with Ki’s of 11.7 ± 1.2 mM and 10.7 ± 0.9 mM respectively. Substrate 
inhibition was observed to a lesser degree at 5 mM indole, with a Ki of 
26.5 ± 2.4 mM. A non-substrate inhibition model was considered; however, the 
data was better fit by a substrate inhibition model (Figure 5.10).  
 
 
Figure 5.10. MalL W531G 5mM Indole Substrate Inhibition Michaelis-Menten fit 
 
Table 5.1. Michaelis-Menten constants for MalL W531G Michaelis-Menten kinetics with 
varying indole concentrations. 
 Indole Concentration 
Parameter 0 mM 0.5 mM 5 mM 
kcat (sec-1) 26.1 ± 0.4 30.6 ± 0.4 25.7 ± 0.2 
KM (mM) 0.0911 ± 0.004 0.0971 ± 0.004 0.123 ± 0.002 




5.4.2 Determination of Indole Inhibition Concentration 
Given the improvement of MalL activity seen with 0.5 mM indole (Section 5.4.1) 
we wanted to find the concentration of indole that would give optimal MalL 
activity. The activity of MalL W531G was therefore assayed in 0.4 mM increments 
up to 4.0 mM indole concentration using a PNG substrate concentration of 1mM 
(approximately 10 X KM) (Figure 5.11). 
 
 
Figure 5.11. Increasing the concentration of indole in a standard assay inhibits the 
activity of MalL W531G at 25°C. Error bars were visible are the standard deviation of 
three replicates. 
 
MalL W531G was found to be inhibited by Indole at as low as 0.4 mM in 
concentration. This is in contrast to the data presented above (Section 5.4.1), 
where indole was found to act as an activator at a concentration of 0.5 mM. 
Activity is progressively decreased with increasing concentrations of indole. These 
data are preliminary and further work is required to resolve the differences 




5.4.3 Temperature Characterisation of W531G  
The response of MalL W531G to temperature was measured as described in 
Section 2.2.2. The data was fitted with a temperature dependant Δ‡ equation. 
 
 
Figure 5.12. Temperature characterisation of MalL W531G fit with the MMRT equation 
using a temperature dependent ΔCP‡. Points are averages of triplicate values. Error bars 
where visible are the standard deviation of three replicates. 
 
MalL W531G shows a curved temperature dependence consistent with MMRT 
(R2 = 0.9976). MalL W531G has a temperature optimum of 314.6 K (41.6°C) and 
the rate is temperature dependant with a Δ‡  of -9.6 ± 0.1 kJ mol-1 K-1 
(T0 = 310.6 K) (Table 5.2). Compared to MalL wildtype MalL W531G has a larger 





Figure 5.13. MalL comparison between W531G and Wildtype 
 
Table 5.2. MMRT fit parameters of MalL W531G and MalL Wildtype  
 Enzyme 
Parameter MalL WT MalL W531G 
T0  (K) 309.4 310.6 
ΔH‡ (T0) (kJ mol-1) 42.9 ± 1.2 39.3 ± 0.5 
ΔS‡ (T0) (J mol-1 K-1) -70.7 ± 3.7 -81.4 ± 1.5 
ΔCP‡ (T0) (kJ mol-1 K-1) -8.5 ± 0.3 -9.6 ± 0.1 
A (kJ mol-1 K-2) -218 ± 15 -221 ± 6 
Topt (K) 313.4 314.6 
 
5.5 Discussion 
A tryptophan to glycine mutation was able to be successfully mutated in MalL. 
Although this mutation does have an effect on the rate, the full extent of the 
interactions with indole was unable to be fully characterised. Overall W531G 
performed reasonably similarly to the wildtype enzyme in the absence of indole.  
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It was expected that the removal of tryptophan would alter the dynamics of the 
C-terminal domain. Given the results of the S536R mutant where we saw a 
decrease in the rate that could be attributed to a rigidified C-terminal domain, we 
thought that a tryptophan mutant could see a change in the enzymatic rate.  
The tryptophan mutants as described by Deckert and colleagues functioned by 
altering the conformation of the active site. Our mutants in contrast aimed to work 
by altering the dynamics of an accessory domain. Changes to the enzymatic rate 
were confirmed by Michaelis-Menten assays which showed that the addition of 
0.5 mM indole increased kcat. Changes were also observed in the KM and Ki, which 
indicates a complex dynamic effect is changing the enzyme rate. 
MalL W531G had a larger Δ‡ than MalL wildtype indicating that the dynamics of 
the reactant state versus the transition state in MalL W531G has been altered. The 
negative Δ‡ in enzymatic reactions comes from a rigidification of the enzyme’s 
dynamics in the transition state. The cause of this increase in Δ‡ could come from 
an increase in the dynamics of the C-terminal domain in the reactant state. 
Addition of indole would therefore restore rigidity to this domain and decrease 
Δ‡ which would be consistent with the results in the indole concentration assay 
(Section 5.4.2). Normal mode analysis (Section 2.5) predicts an overall increase in 





Figure 5.14. Predicted dynamic changes of MalL W531G using normal mode analysis. 
Regions of increased flexibility are coloured red. Regions of decreased flexibility are 
coloured blue. 
 
The indole concentration optimisation assay gave contrasting results to the 
Michaelis-Menten assays. Michaelis-Menten seems to indicate that enzyme 
activity increases with indole concentration, shown by the increase in kcat between 
0 and 0.5 mM indole. This increase appears to be offset by increases in KM which 
results in an inhibitory effect, returning MalL W531G to a basal rate at increased 
indole concentrations (5 mM).  
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The indole concentration assay in contrast showed small decreases in enzyme 
activity with increased indole concentration. The decrease in rate over the 4 mM 
range showed a variation of only 7% (26.5 to 23.7). While the trend is somewhat 
inconsistent it does show a clear decrease. In addition, given the overall small 
change in rate over the tested range, error introduces substantial variability that 
may influence interpretation. Given the contradictory results it is required that 
these assays be repeated to allow for firm conclusions to be drawn.  
Future work would include repeating assays for MalL W531G. In addition, the 
cloning work for MalL W531A should be repeated. Time limitations meant that 
that this was not initially able to be completed. Given the relatively low success 
rate (1 successful mutant from 16 in colony PCR) of mutation a modified PCR 
protocol with a higher fidelity DNA polymerase may be necessary to prevent 
additional mutations from being inserted. MalL W531A would allow for 
characterisation of different binding capacities for indole by reducing the binding 
complementarity to the binding pocket. 
The crystal structure of MalL W531G could provide insights into the mechanism 
by which indole affects the rate. Differences between the apo and indole bound 
structures would allow for the effect of indole to be characterised. In addition, the 
crystal structure will allow for study using molecular dynamics which allows for 




Enzymes are extraordinary biological catalysts that can accelerate the rate of 
chemical reactions by incredible amounts. One important aspect of enzyme 
activity is their response to temperature. Enzymes are very sensitive to 
temperature changes and produce a distinctive curved rate vs temperature profile. 
As temperatures increase enzymatic rate also increases, until a point where the 
rate is at a maximum (called the Topt) followed by a decrease in enzymatic rate. 
The activity of enzymes with regards to temperature has been traditionally 
modelled using the Arrhenius and Eyring equations which predict an exponential 
increase in rate with temperature. Deviations from these models has previously 
been attributed to enzyme denaturation at elevated temperatures. 
It has recently been shown by an increasing body of evidence that these deviations 
are not able to be sufficiently described by enzyme denaturation (Arcus et al., 
2016; Hobbs et al., 2013). Hence, enzymes have a more complicated temperature 
dependence. Macromolecular rate theory (MMRT) describes the temperature 
dependence of enzymes by adding a term for the activation heat capacity to the 
rate equation (Hobbs et al., 2013). The heat capacity of an enzyme is dependent 
on the distribution of vibrational modes for the enzyme molecule (Gómez et al., 
1995). In this study we have used the MMRT equation to fit our enzyme rate vs 
temperature data because of the way it more accurately models the curved 
temperature profile. In using the MMRT equation we also have a tool to calculate 
the change in heat capacity for an enzyme catalysed reaction based on 
experimental data.  
Experimentally, there are a number of approaches we can take to investigate 
enzyme dynamics, one of which includes the binding of ligands. Ligand binding can 
influence the vibrational modes of macromolecules, which will alter the enzyme 
dynamics and therefore alter the heat capacity. Use of MMRT in this study was 
pivotal in order to determine heat capacity changes of the enzyme and any 
changes that may occur to it. MMRT has found a wide range of applicability 
towards biological phenomena including temperature adaptation, and 
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temperature responses from the enzyme level up to an ecosystem scale (Arcus et 
al., 2016; Hobbs et al., 2013; Schipper et al., 2014).  
Allosteric regulation is a widespread phenomenon observed in many enzymes 
whereby an enzyme is regulated by an effector binding at a site other than the 
active site. Despite the widespread use of this type of regulation in biology, the 
underlying mechanisms of allostery are still poorly understood. We hypothesise 
that allosteric enzyme regulation can be achieved using a mechanism that alters 
the heat capacity of an enzyme. To test this, we have developed several mutants 
of the Bacillus subtilis isomaltase enzyme, MalL. MalL has been widely used as a 
model for MMRT and a number of mutants have already been characterised both 
kinetically and structurally (Hobbs et al., 2013). In addition to these mutants, MalL 
has also been characterised bound with urea (unpublished) and bound to a 
transition state analogue (PDB: 5WCZ)  (van der Kamp et al., 2018). 
The wild type (WT) MalL enzyme had previously been characterised with low 
concentrations of urea. This showed that urea could bind to and potentially affect 
the dynamics of MalL. A urea binding site was identified in the C-terminal domain 
of MalL far away from the active site. Analysis of the urea binding site by 
crystallography revealed that bound urea interacted with S536 and E554. Two 
mutants were developed in collaboration with the Institute for Protein Innovation 
to mimic the effect of urea binding. In these mutants, either S536 or V556 were 
mutated to arginine (because of their proximity to the bound urea) to provide 
atoms that would mimic the urea binding site. Additionally, the V556R mutation 
was supported by two additional mutations (E554Q, S536D) which together we 
have termed a triple mutant (TM).  
These two mutants were characterised both kinetically and structurally. MalL 
S536R showed a slight decrease in the rate when characterised using 
Michaelis-Menten kinetics at 25°C. MalL S536R had a kcat of 25.4 ± 0.5 sec-1 
compared to WT with a kcat of 27.1 ± 0.6 sec-1. MalL S536R showed a larger 
decrease in the rate when characterised in a temperature assay. MalL S536R had 
significantly lower activity than WT across a range of temperatures. MalL S536R 
had a kcat of 43.2 ± 1.0 sec-1 compared to WT of 82.9 ± 1.1 sec-1 at 312 K (39°C). 
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The activity assay of MalL S536R with temperature was well described by MMRT 
(R2 = 0.9979) with a slight increase in the Topt. MalL S536R had an increased Δ‡ 
of -7.4 ± 0.2 kJ mol-1 K-1 (T0 = 312.8 K) compared to WT (-8.5 ± 0.3 kJ mol-1 K-1 
(T0 = 309.4 K)). In addition, Δ‡  was not as strongly dependent on temperature as 
in the WT enzyme, with an A value of -139 ± 9 kJ mol-1 K-2 compared 
to -218 ± 15 kJ mol-1 K-2 in WT. These results are consistent with an overall 
rigidification of the enzyme when compared to WT. 
The kinetic results were corroborated by analysis of the crystal structure of MalL 
S536R. MalL S536R showed the same general domain architecture to MalL WT. 
The S536R mutation successfully occupied the same space as urea (as in the WT 
urea structure). B-factor analysis suggests an overall increase in rigidity across the 
entire enzyme. In addition, the crystals diffracted to very high resolution (1.10 Å) 
and this also suggests that the enzyme molecules are more ordered in the crystal.  
Similar to MalL S536R, the MalL TM introduced an arginine at position 556 that 
also occupied the same space as urea. In contrast to MalL S536R, the TM showed 
an overall increase in the rate compared to WT. The kcat in the TM was increased 
to 34.3 ± 1.0 sec-1 from 27.1 ± 0.6 sec-1 in WT. Similarly, the TM showed an 
increase in rate in the temperature assay. MalL TM saw a decrease in Δ‡ 
to -9.3 ± 0.1 kJ mol-1 K-1 (T0 = 309.1 K) from -8.5 ± 0.3 kJ mol-1 K-1 (T0 = 309.4 K). 
This is consistent with an increase in flexibility across the enzyme. This was also 
represented in the crystal structure which showed an increase in flexibility across 
the second half of the enzyme including the C-terminal domain (as indicated by 
B-factor values).  
In addition to the S536R and TM mutants a third W531G mutant was constructed. 
Through MalL W531G, we attempted to engineer an allosteric rescue site into the 
C-terminal domain. Tryptophan is bulky and thus acts as a hydrophobic supporting 
residue and its removal therefore potentially disrupts the structure and dynamics 
of the C-terminal domain. Chemical mimicry of the removed tryptophan moiety 
(by addition of indole) is hypothesised to restore the disrupted structure. Results 
from the S536R and TM mutants showed that small changes to this domain could 
have significant effects on the rate.  
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Kinetic assays of MalL W531G showed conflicting results. In Michaelis-Menten 
assays with increasing indole concentration, MalL W531G saw activation at low 
concentrations of indole. In contrast to this, in an indole concentration assay 
W531G showed increasing inhibition with indole concentration. W531G has a 
decreased Δ‡  [-9.6 ± 0.1 kJ mol-1 K-1 (T0 = 310.6 K)] compared to WT 
[-8.5 ± 0.3 kJ mol-1 K-1 (T0 = 309.4 K)]. This would seem to indicate an increase in 
flexibility caused by the W531G mutation which may be restored with the addition 
of indole. 
All three mutations were approximately 30 Å from the active site in the C-terminal 
domain. These mutations had significant effects on the enzymatic rate across this 
distance. Overall the structures of MalL TM and S536R were very similar to WT 
and only showed minor deviations in structure. Analysis of RMSD values of MalL 
TM and S536R to WT chain A (PDB: 4M56) showed values of 0.570 Å and 0.325 Å, 
respectively. This indicates an overall high degree of similarity between the 
different structures. Changes to the rate can therefore be attributed to changes in 
enzyme dynamics and the enzymes heat capacity. 
This study hypothesised that allosteric enzyme regulation can be achieved using a 
mechanism that alters the heat capacity of an enzyme. We utilised MMRT to 
investigate the heat capacity of the enzyme MalL and how this could be altered by 
strategic mutation of specific residues. Robust kinetic data was collected using a 
specialised Stopped-Flow apparatus and two crystallographic structures were 
solved during this investigation. Our results are a promising first step in showing 
how changes in enzyme activity can be linked to changes in enzyme dynamics in 
auxiliary domains far from the active site using MMRT and heat capacity as a 
model. 
 
6.1 Future Work 
Some inconsistencies were observed in the kinetics of MalL W531G and S536R so 
these would need to be further investigated and repeated. MalL W531G showed 
a contrasting result to indole between assays. In both assays performed indole 
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influenced enzyme activity. This indicates that the system is well suited for further 
studying the effects of allostery. If the allosteric response in MalL W531G can be 
optimised other mutations (such as S536R) could potentially be introduced to 
probe how multiple mutations alter enzyme dynamics in relation to each other. 
Obtaining a crystal structure for MalL W531G with and without indole bound could 
give key insights into the mechanisms of allostery. In addition, the W531A mutant 
could be re-cloned and similarly characterised. The W531A mutant would allow 
for characterisation of allostery with different binding affinities of indole by 
introducing a small steric constraint in the binding pocket. 
Some work has been done to produce a MalL mutant without the C-terminal 
domain (unpublished), however this failed to produce soluble protein. Additional 
constructs are being designed in collaboration with the Institute for Protein 
Innovation (Harvard) to pursue obtaining soluble constructs. Kinetic and structural 
characterisation of these mutants would give insights into the function of the 
C-terminal domain as a whole and provide context to the ability of mutations in 
this domain to affect the rate. 
Molecular dynamics simulations would well complement the current kinetic and 
structural data collected. Molecular dynamics allows for an atomic level overview 
of the link between structural changes and enzyme dynamics. This would provide 
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7.1 Gene and protein sequences of MalL variants 
Mutation positions for MalL variants are in bolded and underlined. 
7.1.1 MalL WT 













































7.1.2 MalL S536R 














































7.1.3 MalL TM 













































7.1.4 MalL W531G 















































7.2 Example analysis of kinetic data 
Initial kinetic data (Vmax) is collected as change in absorbance per second by linear 
regression of the first 10 seconds of rate data (Table 7.1). The Vmax is converted to 
M sec-1 by dividing by the extinction coefficient for the enzyme at the relevant pH 
and wavelength (13270 M-1) (Kraakman, 2017) (Table 7.2). The kcat is then calculated 
by dividing by the enzyme concentration (1.87 X 10-7 M) (Table 7.3). Temperature 
data is plotted as the natural log of kcat versus temperature. This data can be seen in 
Section 3 (Figure 3.11). 
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Table 7.1.Example linear regression of spectroscopy data 
  Vmax (ΔAbs sec-1) 






288.0 0.01446 0.01515 0.01467 0.0147 
292.7 0.02773 0.02902 0.02873 0.02882 
297.7 0.05556 0.05555 0.05519 0.0549 
302.6 0.09339 0.09609 0.09514 0.09515 
305.9  0.13791 0.14062 0.14084 
307.6  0.17075 0.17022 0.17012 
309.7  0.19833 0.19563 0.19771 
311.9  0.20672 0.20792 0.20713 
313.8  0.20159 0.20019 0.2001 
315.9  0.21916 0.22114 0.22076 
317.8  0.19737 0.20065 0.19952 








288.1 0.00954 0.00978 0.00969 0.00982 
292.8 0.01808 0.0185 0.01834 0.01815 
297.6 0.0331 0.03257 0.0329 0.03265 
302.7 0.05533 0.05479 0.05555 0.05507 
307.4 0.08154 0.08576 0.08668 0.08647 
311.8  0.11055 0.11214 0.11257 
313.9 0.11501 0.11717 0.11748 0.11682 
315.9 0.11118 0.1158 0.11552 0.11574 
317.9  0.12368 0.12442 0.12346 
319.9 0.11303 0.11673 0.11665 0.11644 
321.8 0.10125 0.09957 0.09935 0.09949 





Table 7.2. Example calculation of Vmax 
 
 
Vmax (M sec-1) 






288.1 1.08968E-06 1.14167E-06 1.1055E-06 1.10776E-06 
292.8 2.08968E-06 2.18689E-06 2.16503E-06 2.17182E-06 
297.6 4.18689E-06 4.18613E-06 4.15901E-06 4.13715E-06 
302.7 7.03768E-06 7.24115E-06 7.16956E-06 7.17031E-06 
307.4 
 
1.03926E-05 1.05968E-05 1.06134E-05 
311.8 
 
1.28674E-05 1.28274E-05 1.28199E-05 
313.9 
 
1.49457E-05 1.47423E-05 1.4899E-05 
315.9 
 
1.5578E-05 1.56684E-05 1.56089E-05 
317.9 
 
1.51914E-05 1.50859E-05 1.50791E-05 
319.9 
 
1.65154E-05 1.66647E-05 1.6636E-05 
321.8 
 
1.48734E-05 1.51206E-05 1.50354E-05 
323.7 
 








288.1 7.18915E-07 7.37001E-07 7.30219E-07 7.40015E-07 
292.8 1.36247E-06 1.39412E-06 1.38206E-06 1.36775E-06 
297.6 2.49435E-06 2.45441E-06 2.47928E-06 2.46044E-06 
302.7 4.16956E-06 4.12886E-06 4.18613E-06 4.14996E-06 
307.4 6.14469E-06 6.4627E-06 6.53203E-06 6.5162E-06 
311.8  8.33082E-06 8.45064E-06 8.48304E-06 
313.9 8.66692E-06 8.82969E-06 8.85305E-06 8.80332E-06 
315.9 8.3783E-06 8.72645E-06 8.70535E-06 8.72193E-06 
317.9  9.32027E-06 9.37604E-06 9.30369E-06 
319.9 8.51771E-06 8.79653E-06 8.7905E-06 8.77468E-06 
321.8 7.62999E-06 7.50339E-06 7.48681E-06 7.49736E-06 
















288.1 5.82714 6.10520 5.91177 5.92386 
292.8 11.17474 11.69459 11.57772 11.61399 
297.6 22.38977 22.38574 22.24067 22.12380 
302.7 37.63465 38.72270 38.33987 38.34390 
307.4 
 
55.57548 56.66757 56.75622 
311.8 
 
68.80947 68.59588 68.55559 
313.9 
 
79.92376 78.83570 79.67391 
315.9 
 
83.30479 83.78837 83.47001 
317.9 
 
81.23748 80.67331 80.63704 
319.9 
 
88.31791 89.11581 88.96268 
321.8 
 
79.53689 80.85868 80.40331 
323.7 
 








288.1 3.84446 3.94118 3.90491 3.95730 
292.8 7.28595 7.45520 7.39072 7.31415 
297.6 13.33876 13.12518 13.25816 13.15742 
302.7 22.29709 22.07948 22.38574 22.19231 
307.4 32.85929 34.55988 34.93063 34.84600 
311.8  44.54985 45.19059 45.36387 
313.9 46.34715 47.21760 47.34252 47.07655 
315.9 44.80373 46.66551 46.55268 46.64133 
317.9  49.84102 50.13923 49.75237 
319.9 45.54925 47.04029 47.00805 46.92342 
321.8 40.80210 40.12509 40.03643 40.09285 





7.3 Summary kinetic data 
7.3.1 Michaelis-Menten kinetics  
 
Table 7.4. Summary Michaelis-Menten constants for MalL Variants 
 Enzyme 
























































7.3.2 Temperature characterisation 
 













T0 (K) 309.4 312.8 309.1 310.6 305.7 












































Topt (K) 313.4 316.8 313.1 314.6 309.7 
 
